PMID,FACTOR,TEXT
34600737,Gender,"adjusted means los were higher for patients with picc lines compared to midlines, in both females and males."
34218708,Chemotherapy,"more than 1 million peripherally inserted central catheters (picc) are placed annually in the us and are used to provide convenient vascular access for a variety of reasons including long term antibiotic treatment, chemotherapy, parenteral nutrition, and blood draws."
34218708,Total parenteral nutrition,"more than 1 million peripherally inserted central catheters (picc) are placed annually in the us and are used to provide convenient vascular access for a variety of reasons including long term antibiotic treatment, chemotherapy, parenteral nutrition, and blood draws."
34218708,PICC infection,"although they are relatively easy to place and inexpensive, picc line use is associated with many complications such as phlebitis/thrombophlebitis, venous thrombosis, catheter-related infection, wound infection, and central vein stenosis."
37314592,Chemotherapy,"purpose: there is a lack of studies that systematically evaluate the clinical factors of picc-rvt such as treatment, tumor stage, metastasis, and chemotherapy drugs in cancer patients. meta-analysis of these studies indicated that a history of chemotherapy, tumor type, tumor stage, presence or absence of metastasis, and use of fluorouracil, etoposide, platinum drugs, and taxane were all risk factors for picc catheter thrombosis in cancer patients."
37314592,Cancer,"clinical factors of picc-rvt in cancer patients: a meta-analysis. purpose: there is a lack of studies that systematically evaluate the clinical factors of picc-rvt such as treatment, tumor stage, metastasis, and chemotherapy drugs in cancer patients. this study, therefore, aims to evaluate the clinical factors of catheter-related venous thrombosis in cancer patients with indwelling picc to provide a basis for the clinical prevention and reduction of thrombosis. meta-analysis of these studies indicated that a history of chemotherapy, tumor type, tumor stage, presence or absence of metastasis, and use of fluorouracil, etoposide, platinum drugs, and taxane were all risk factors for picc catheter thrombosis in cancer patients. based on the present evidence at hand, radiotherapy cannot be considered to be related to the formation of picc-rvt in cancer patients."
24811591,ICU,"there are no randomized controlled trials (rcts) on the best treatment of picc-related thrombosis in the intensive care unit (icu) setting and in most cohort studies, anticoagulation strategies with or without picc removal have been used."
24811591,PICC infection,"however, piccs are associated with a number of complications, particularly upper extremity venous thrombosis (uevt), leading to post-thrombotic syndrome, pulmonary embolism and increased risk of catheter-related infection."
30697126,Chemotherapy,"aims: peripherally inserted central catheters(picc) lines are becoming increasingly popular in solid cancer patients for the administration of chemotherapy. conclusions: vte is a common complication in medical oncology patients who underwent insertion picc line insertion for chemotherapy. we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt."
30697126,Cancer,predictive risk factors of venous thromboembolism (vte) associated with peripherally inserted central catheters (picc) in ambulant solid cancer patients: retrospective single centre cohort study. aims: peripherally inserted central catheters(picc) lines are becoming increasingly popular in solid cancer patients for the administration of chemotherapy.
30697126,BMI,"we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt."
30697126,Smoking,"we concluded that high bmi,high plts count and fluropyrimidine containing chemotherapy are all significant risk factors for vte events recorded while smoking and high bmi are significantly contributing to the high rate of the picc line related dvt."
30697126,PICC insertion procedure,risk of distant vte is high as well as the picc line related dvt and the risk of the picc line related dvt is higher in the first two weeks after picc insertion.
28796444,Cancer,risk factors associated with picc-dvt included: history of dvt; multi-lumen picc; active cancer; presence of another cvc when the picc was placed; and white blood cell count greater than 12 000.
28796444,PICC insertion procedure,conclusion the michigan picc-dvt risk score offers a novel way to estimate risk of dvt associated with piccs and can help inform appropriateness of picc insertion.
28796444,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),risk factors associated with picc-dvt included: history of dvt; multi-lumen picc; active cancer; presence of another cvc when the picc was placed; and white blood cell count greater than 12 000.
31324590,PICC infection,"numbers of picc delegated to technicians, and picc placement difficulties, were prospectively recorded for the whole study population whereas complications such as picc infection, deep venous thrombosis and catheter occlusion were prospectively recorded until picc removal for a subgroup of patients included during one month. complications included 8 picc-related infections (8/77; 10.4%), 3 deep venous thromboses (3/77; 3.9%) and 9 catheter occlusions (9/77; 11.7%)."
36601900,Slower blood flow velocity,conclusions: exercise therapy improved venous blood flow velocity and effectively reduced the incidence of picc-associated vte.
35802673,PICC infection,"in 2017, 5 of 429 piccs developed a central line-associated infection (1.2%) and 29 of 429 piccs developed symptomatic venous thromboembolism (6.7%)."
33889013,Chemotherapy,"risk factors of picc-related venous thrombosis in breast cancer patients undergoing chemotherapy. background: to analyze the risk factors of a peripherally inserted central catheter (picc)-related venous thrombosis in patients with breast cancer undergoing chemotherapy and explore its preventive measures. methods: data of 780 patients with breast cancer who underwent picc chemotherapy in our hospital from january 2014 to june 2015 were retrospectively analyzed. thrombosis was not associated with age, punctured limb, platelet count, or chemotherapy drugs (p > 0.05). conclusion: blood vessel puncture was the main factor that affected picc-related thrombosis in breast cancer chemotherapy."
33889013,Cancer,"risk factors of picc-related venous thrombosis in breast cancer patients undergoing chemotherapy. background: to analyze the risk factors of a peripherally inserted central catheter (picc)-related venous thrombosis in patients with breast cancer undergoing chemotherapy and explore its preventive measures. methods: data of 780 patients with breast cancer who underwent picc chemotherapy in our hospital from january 2014 to june 2015 were retrospectively analyzed. results: among the 780 patients with breast cancer, 36 developed picc-related venous thrombosis. conclusion: blood vessel puncture was the main factor that affected picc-related thrombosis in breast cancer chemotherapy."
33889013,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"thrombosis was not associated with age, punctured limb, platelet count, or chemotherapy drugs (p > 0.05)."
33719694,PICC infection,"no serious complications such as infection, thrombosis and extravasation occurred in this group of patients after treatment."
36897677,PICC infection,"synthesized outcomes indicated that compared with willful grip exercises, quantified grip exercises reduced the incidence of picc-related thrombosis (odds ratio = 0.19, 95% confidence interval [ci]: 0.12-0.31) and infection (odds ratio = 0.30, 95% ci: 0.15-0.60) in picc patients, increased the maximum venous velocity (mean difference = 3.02, 95% ci: 1.87-4.17) and mean blood flow (mean difference = 3.10, 95%ci: 1.57-4.62) in picc patients (all p < .05). conclusion: quantified grip exercises can effectively reduce the occurrence of picc-related thrombosis and infection, improve the venous hemodynamics."
23715775,Diabete,"a diagnosis of diabetes was the only factor that significantly predicted complications (hazard ratio, 2.71; 95% confidence interval, 1.13-6.13)."
23715775,PICC insertion procedure,"however, little is known about the consequences of picc insertion in these patients. materials and methods: pregnant women with picc insertion between january 2000 and june 2006 were studied retrospectively. conclusions: picc insertion in pregnant women is associated with a high complication rate, which appears to be independent of the type of infusate and occurs in the majority of women."
37573601,ICU,"predictive model for picc occlusion risk for patients in intensive care units: a retrospective clinical study. context: peripherally inserted central catheters (piccs) have a high incidence of catheter occlusion, but research exploring the risk factors for such an occlusion for patients in intensive care units (icus) is lacking."
37573601,Diabete,"results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001). the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001. conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor."
37573601,BMI,"results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001). the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001. conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor."
37573601,Age,"results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001). the independent risk factors for picc occlusion included: (1) age ≥65 years-or=1.224, p = .028; (2) bmi ≥24 kg/m2-or=1.679, p = .004; (3) diabetes-or=1.343, p = .017; (4) malignant tumors-or=2.736, p < .001; (5) blood transfusions-or=1.947, p < .001), and (6) intravenous nutrition-or=2.021, p < .001. conclusions: age ≥65 years, bmi ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for picc occlusion, while the frequency of flushing and sealing pipe (q8h) was a protective factor."
37573601,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)."
37573601,Hypertension,"results: the univariate analysis showed that 13 factors were associated with picc occlusion, including: (1) an age ≥65 years (p < .001), a bmi of ≥24 kg/m2 (p < .001), (2) a bmi of ≥24kg/m2 (p = .002), (3) diabetes (p < .001), (4) stroke (p < .001), (5) hypertension (p < .001), (6) malignant tumors (p < .001), (7) a history of deep vein thrombosis (p < .001), (8) limb activity (p < .001), (10) flushing and sealing pipe frequency of q8h (p = .035), (11) retention time (p < .001), (12) an increased platelet count (p = .036), (13) blood transfusions (p < .001), and (14) intravenous nutrition (p < .001)."
34540095,Chemotherapy,"predisposing factors and effect of bundle nursing in picc-related upper extremity deep venous thrombosis in patients with non-hodgkin's lymphoma undergoing chemotherapy. objective: to explore the effects of bundle nursing on picc-related upper extremity deep venous thrombosis (picc-uedvt) in patients with non-hodgkin's lymphoma (nhl) who are undergoing chemotherapy, and contributing factors toward picc-uedvt. methods: 370 nhl patients undergoing chemotherapy in the department of hematology were selected prospectively and randomized into a control group (receiving routine nursing) and an observation group (receiving bundle nursing) using random number method."
34540095,Cancer,"predisposing factors and effect of bundle nursing in picc-related upper extremity deep venous thrombosis in patients with non-hodgkin's lymphoma undergoing chemotherapy. objective: to explore the effects of bundle nursing on picc-related upper extremity deep venous thrombosis (picc-uedvt) in patients with non-hodgkin's lymphoma (nhl) who are undergoing chemotherapy, and contributing factors toward picc-uedvt."
34540095,Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h,"tumor stage, ecog score >2, hemoglobin <100 g/l, and d-dimer >0.5 mg/l were factors that contributed to the occurrence of picc-uedvt in nhl patients (p<0.05). conclusion: tumor stage, ecog score >2, reduced hemoglobin, and increased d-dimer levels are predisposing factors for picc-uedvt in nhl patients."
34738565,Cancer,"peripherally inserted central venous catheters (picc) versus totally implantable venous access device (port) for chemotherapy administration: a meta-analysis on gynecological cancer patients. background and aim: ninety-four thousand gynecological cancer diagnoses are performed each year in the united states. this meta-analysis aims to compare port and peripherally inserted central catheter (picc) outcomes during adjuvant treatment for gynecological cancer. unless specific contraindications, ports can be preferred for systemic treatment in gynecological cancer patients."
36747971,Smoking,"additionally, the number of smoking histories in the thrombosis group (18, 38.30%) was significantly higher than that in the nonthrombosis group (5, 9.80%). b) logistic regression analysis indicated that rdw and smoking history were independent risk factors for picc-related thrombosis (or: 3.028, p<0.001; or: 5.640, p=0.023). c) the area under the receiver operating characteristic (roc) curve of the combination of rdw and smoking history was 86.8%, and the sensitivity and specificity for predicting thrombosis after picc were 85.1% and 80%, respectively. d) cox regression analysis revealed that rdw and smoking history were independent risk factors for picc-related thrombosis (p<0.001). conclusion: the combined use of rdw and smoking history has early evaluation and predictive value in the diagnosis of picc-related thrombosis."
34723657,PICC infection,bridging the gap: introduction of an antimicrobial peripherally inserted central catheter (picc) in response to high picc central line-associated bloodstream infection incidence. objective: to reduce the incidence of central line-associated bloodstream infection (clabsi) in peripherally inserted central catheters (picc) through the introduction of an antimicrobial (am) catheter as recommended in evidence-based guidelines and standards. design: quality improvement project comparing incidence of infections pre-implementation and postimplementation of the new catheter.
31387422,PICC infection,"the rate of deep vein thrombosis (0.31-1.48/1000 cds) and occlusion differed across the picc types, while the rate of central line-associated bloodstream infection (0.53-0.74/1000 cds) did not."
32195936,Cancer,"the clinical features and related factors of picc-related upper extremity asymptomatic venous thrombosis in cancer patients: a prospective study. peripherally inserted central venous catheter (picc) is the main venous access for cancer patients when they receive chemotherapy and nutritional support, but picc-related venous thrombosis has become one of the most common and serious complications. it is very important to further explore the relationship among these features, so that prevent and treat the picc-related thrombosis.to investigate the clinical features and the related factors of picc-related upper extremity asymptomatic venous thrombosis in cancer patients, and to provide theoretical basis for the prevention of venous thrombosis.a total of 127 tumor patients with picc catheterization were selected."
32195936,Slower blood flow velocity,"the clinical characteristics and influencing factors of asymptomatic thrombosis such as vessel diameter, blood flow velocity, thrombosis time, location, and the thrombosis stages were recorded.the incidence of picc-related upper limbs asymptomatic thrombosis was 48.82% (62/127), and the median time was 3 days. the group trajectory analysis indicated the 3 changes of blood flow velocity during the follow-up period: downward trend, upward trend, and steady fluctuations. cox proportional hazards model suggested that the patient's eastern cooperative oncology group score (hazard ratio [hr] 2.791, 95% confidence interval [ci] 0.08-0.76) and blood flow velocity (hr 0.250, 95% ci 2.01-3.87) was the risk of picc-related asymptomatic thrombosis.picc catheterization can affect blood flow and asymptomatic thrombosis can occur at an early stage."
27161689,Cancer,"whereas those with picc associated infection (n=18), 5 had non-hodgkin's lymphoma and 5 had acute lymphoid leukaemia."
27161689,Age,the mean age of patients who has picc associated thrombosis was 51.6 years (±8.1 years).
27161689,PICC infection,"although generally regarded safe, infections and thrombotic events have occurred with picc use, necessitating study to guide future clinical prophylaxis and management. the main outcome measures were picc associated thrombosis and/or infection results: of 131 picc placements in a total of 90 patients. thrombosis was found in 14.5% (n=19), 13.7% developed infection (n=18) and remaining were without complications. whereas those with picc associated infection (n=18), 5 had non-hodgkin's lymphoma and 5 had acute lymphoid leukaemia. decreased in picc lumen size was shown to influence the risk of complications; of 5 french catheters, 20% had thrombosis and 15% had infection, vs."
31724074,Cancer,"purpose: the use of central venous catheters with peripheral insertion (picc) has increased rapidly in recent years, particularly in cancer patients."
37445515,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"study precision was evaluated by using a funnel plot for platelets level. picc-related dvt was associated with higher d-dimers (0.37 μg/ml, 95% ci 0.02, 0.72; p = 0.04, i(2) = 92%; p for heterogeneity < 0.00001) and with higher platelets (8.76 × 10(9)/l, 95% ci 1.62, 15.91; p = 0.02, i(2) = 41%; p for heterogeneity = 0.06). conclusions: high levels of d-dimer and platelet were associated with dvt in patients with picc. however, biomarkers such as aptt, fibrinogen, fdp, glucose, hemoglobin, glycated hemoglobin, inr, prothrombin time, prothrombin fragment 1.2, the thrombin-antithrombin complex, and wbc were not related to the development of dvt associated with picc."
35071472,Anticoagulants therapy,"results: after picc removal, no patients in the anticoagulation therapy group developed progressive thrombosis, while 10 patients in the catheter removal alone group developed progressive thrombosis or pulmonary embolism (pe), including one case of pe, four cases of secondary upper extremity deep vein thrombosis (uedvt), and five patients showed obvious aggravation of thrombosis after catheter removal, and were administered repeated anticoagulant therapy."
33617142,Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h,"a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis."
33617142,Slower blood flow velocity,"a higher eastern cooperative oncology group score (ecog), slower blood flow velocity and left basilic vein were independent risk factors of asymptomatic thrombosis."
32921123,Chemotherapy,"effects of tai chi on catheter management and quality of life in tumor patients with picc at the intermission of chemotherapy: a non-inferiority randomized controlled trial. background: peripherally inserted central catheter (picc) is widely used in chemotherapy due to its minimal complications and simple wound care. this study explored the effects of tai chi on catheterrelated complications, catheter management ability, and quality of life in tumor patients with picc at the intermission of chemotherapy. a total of 98 patients with malignant tumors who underwent long-term chemotherapy with picc were randomly divided into an observation group (49 cases) and a control group (49 cases)."
32921123,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"results: after the intervention, the activated partial thromboplastin time (aptt) and prothrombin time (pt) in the observation group were longer than those in the control group, while fibrinogen (fib) was lower than that in the control group (all p<0.05)."
25726426,Surgery_type of surgery,"patients with picc-dvt were more likely to have a history of venous thromboembolism (or 1.70, 95% ci=1.02-2.82) or have undergone surgery while the picc was in situ (or 2.17, 95%ci=1.17-4.01 for surgeries longer than two hours)."
28386787,PICC infection,"reasons for removal were that picc was not considered to be useful any longer (16), suspicion of infection (inflammation without documentation) (5) or infection (2), patient's wish (4), death (4), accidental withdrawal (2), puncture site bleeding (1), and catheter change due to extracorporeal photopheresis (1). three venous thromboses were reported (8%), requesting one picc removal because of associated infection."
37553006,Cancer,"upper limb lymphedema impacts the risk of peripherally inserted central catheter-related thrombosis in patients with breast cancer. there is little information on the risk for catheter-related thrombosis in patients with upper limb lymphedema following breast cancer treatment. we investigated the association between upper limb lymphedema and the risk of peripherally inserted central catheterrelated thrombosis (picc-rt) occurring in the contralateral limb of patients with breast cancer. a retrospective review analyzed all patients with breast cancer who underwent picc insertion at a cancer hospital in hunan province from 2015 to 2019. in breast cancer patients, upper limb lymphedema may be an important predictor for picc-rt in the contralateral limb and information should be provided to patients."
34613657,Cancer,"development of a risk score to predict peripherally inserted central catheter thrombosis in active cancer. aims: to explore the prevalence of symptomatic picc thrombosis and pulmonary embolism (pe)/deep vein thrombosis (dvt) in cancer and non-cancer cohorts. in active cancer, we assessed the khorana risk score (krs) and michigan risk score (mrs) for predicting picc thrombosis and modifications to improve discriminative accuracy. methods: we reviewed consecutive cancer patients receiving chemotherapy through a picc inserted april 2017 to july 2018. for each case, we identified a contemporaneous non-cancer control. results: among 147 cancer patients, median age 64 years, picc duration 70 days (range, 2-452), 7% developed picc thrombosis (95% confidence interval (ci) 3.6-12.2) and 4% (95% ci 2-9) pe/dvt. in our cancer cohort, no krs < 1 patients developed picc thrombosis (95% ci 0-11) compared with 9% (95% ci 5-16) in krs ≥ 1 (p = 0.12). conclusion: cancer patients had longer picc durations and higher picc thrombosis rates than those without (7% vs 0.7%)."
35216538,PICC infection,"furthermore, the authors found that only 1.85% of all catheters developed local infection within d8, and only 0.83% evolved in vein thrombosis. total bloodstream infection was at 0.1%."
33148905,Cancer,"safe central venous catheters for esophageal cancer treatment.  introduction : central venous catheter (cvc) use is essential for treating esophageal cancer. methods : we retrospectively investigated complications at the catheter insertion and post-insertion for 199 patients' esophageal cancer treatment (cicc : 45, picc : 154) from 2013 to 2018. conclusion : piccs are safer and more effective than ciccs for the treatment of esophageal cancer, and reduce the incidence of crbsi."
33148905,PICC infection,the incidence of catheter-related blood stream infection (crbsi) was significantly lower in picc than cicc patients (0.3 vs.
25910751,Cancer,"purpose: the use of peripherally inserted central catheters (picc) as an alternative to other central venous access devices (cvad) is becoming very frequent in cancer patients. cox regression analyses of variables associated to crbsis and to crtcs showed that only the type of disease (acute leukemia compared to other diseases) was significantly associated to a higher incidence of crbsis, while no feature was predictive for a higher risk of crtcs."
25910751,PICC infection,"catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (picc). to evaluate the impact of complications associated to these devices in patients with hematologic malignancies, we revised the catheter-related bloodstream infections (crbsi) and the catheter-related thrombotic complications (crtc) observed at our institute between january 2009 and december 2012."
25593110,PICC insertion procedure,"the size of the vein used for picc insertion and thus the catheter to vein ratio is thought to be a controllable factor in the reduction of vte rates in patients who have a picc. however, an optimal catheter to vein ratio for picc insertion has not previously been investigated to inform clinical practice. method: adult patients waiting for picc insertion at a large metropolitan teaching hospital were recruited between may and december 2013. vein diameter at the picc insertion site was measured using ultrasound with in-built callipers."
32441173,PICC infection,"the primary outcomes were maternal infection (cellulitis, sepsis), venous thromboembolism (vte), or combined major complication rate. the risk of infection associated with picc use was the most variable, with rates ranging from 4% to 37%. this suggests that infection risk may be modifiable and further studies are needed to assess interventions that may lower this risk."
33782091,PICC infection,"logistic regression and poisson models were fit to assess the association between appropriateness and complications (composite of catheter occlusion, venous thromboembolism (vte) and central line-associated bloodstream infection (clabsi))."
34511570,Chemotherapy,"risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia. however, the risks of picc-related complications during chemotherapy for acute myeloid leukemia (aml) are not fully understood. conclusion low picc-related complication rates, possibly associated with high rates of catheter removal, were observed during intensive chemotherapy for aml."
34511570,Cancer,"risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia. however, the risks of picc-related complications during chemotherapy for acute myeloid leukemia (aml) are not fully understood."
34511570,BMI,obesity put patients at an increased risk for crt.
34511570,PICC infection,"the incidence rate of catheter-related bloodstream infection (crbsi) was 2.4% at 30 days, and women were more likely to suffer from crbsi than men."
33249623,Chemotherapy,"based on the multivariate analysis, history of smoking [or 2.49 (1.13-5.46), p < .05], use of carboplatin [or 2.23 (1.19-4.17), p < .05] or docetaxel [or 7.23 (1.65-31.56), p < .05], picc size [or 3.52 (1.78-6.99), p < .001], and level of d-dimer [or 5.32 (2.39-11.83), p < .001] were significant risk factors of picc-rt."
33249623,Cancer,"incidence and risk factors of symptomatic thrombosis related to peripherally inserted central catheter in patients with lung cancer. aims: to determine the incidence and risk factors associated with peripherally inserted central catheter-related thrombosis (picc-rt) in patients with lung cancer. methods: patients with lung cancer receiving picc insertion during 1 march 2014-31 may 2019 at a tertiary hospital in shanghai, china were enrolled (n = 748). our findings provided evidence for the management of picc-rt in patients with lung cancer."
33249623,Smoking,"based on the multivariate analysis, history of smoking [or 2.49 (1.13-5.46), p < .05], use of carboplatin [or 2.23 (1.19-4.17), p < .05] or docetaxel [or 7.23 (1.65-31.56), p < .05], picc size [or 3.52 (1.78-6.99), p < .001], and level of d-dimer [or 5.32 (2.39-11.83), p < .001] were significant risk factors of picc-rt."
31900609,PICC infection,"catheter-related bloodstream infections (crbsi) occurred in 32% of patients (2.5/1000 picc days), associated with thrombosis in 8 cases."
34794291,Cancer,"the inclusion criteria were patients with advanced malignant tumor after bilateral breast cancer lymphadenectomy or superior vena cava obstruction syndrome; bedridden patients; and patients without mental disorders; who could understand the content of this study and agreed to participate in this study. conclusion: the indications for picc through the lower limbs in adults include patients with advanced malignant tumor after bilateral breast cancer lymphadenectomy or superior vena cava obstruction syndrome, and mainly bedridden patients."
34794291,Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h,"the inclusion criteria were patients with advanced malignant tumor after bilateral breast cancer lymphadenectomy or superior vena cava obstruction syndrome; bedridden patients; and patients without mental disorders; who could understand the content of this study and agreed to participate in this study. conclusion: the indications for picc through the lower limbs in adults include patients with advanced malignant tumor after bilateral breast cancer lymphadenectomy or superior vena cava obstruction syndrome, and mainly bedridden patients. key words: lower limb picc, deep venous catheterisation, advanced malignant tumor, bedridden."
34794291,PICC infection,no catheter-related infection was found in the two groups of patients.
30683751,PICC infection,"during the 70-day follow-up period, 61.4% of patients reported signs of at least one complication, including potentially serious complications, such as bloodstream infection (17.6%) and deep vein thrombosis (30.6%)."
37333869,PICC insertion procedure,methods: a retrospective analysis of picc insertions and follow-up during a 9 years period to look at patient demographics and infections related to picc was carried out.
37333869,PICC infection,"peripherally inserted central catheters-associated blood stream infections-occurrence, risk factors, and pathogens, a single center study. aim: this study was carried out to understand picc-related complications, specifically infections and causal pathogens, in a tertiary care hospital in kerala, south india. methods: a retrospective analysis of picc insertions and follow-up during a 9 years period to look at patient demographics and infections related to picc was carried out. commonest complication was thrombosis followed by infection, either picc-associated bloodstream infection (pabsi) or local infection (li). conclusion: thrombosis and infection were the commonest picc-related complications."
26207019,Chemotherapy,"we aimed to scrutinize the incidence and risk factors for picc-related upper extremity venous thrombosis (uevt) in patients with lung cancer receiving chemotherapy. patients and methods: we performed a retrospective cohort study of patients with lung cancer with picc insertion undergoing chemotherapy. results: a total of 328 patients with lung cancer having picc undergoing chemotherapy were included, for a total of 34 895 catheter days. patients treated with etoposide had a higher risk of picc-related uevt (or: 3.6; 95% ci: 1.1-12.1; p = .042). conclusion: patients with lung cancer harboring an advanced disease or treating with etoposide were at higher risk of picc-uevt."
26207019,Cancer,"peripherally inserted central catheter-related vein thrombosis in patients with lung cancer. background: peripherally inserted central venous catheters (piccs) are widely used in patients with cancer. we aimed to scrutinize the incidence and risk factors for picc-related upper extremity venous thrombosis (uevt) in patients with lung cancer receiving chemotherapy. patients and methods: we performed a retrospective cohort study of patients with lung cancer with picc insertion undergoing chemotherapy. patient-, catheter-, and insertion-related factors were analyzed in univariable and multivariable logistic regression to identify significant independent risk factors for picc-uevt in patients with lung cancer. results: a total of 328 patients with lung cancer having picc undergoing chemotherapy were included, for a total of 34 895 catheter days. conclusion: patients with lung cancer harboring an advanced disease or treating with etoposide were at higher risk of picc-uevt."
33499716,PICC infection,"catheter-associated infections, dislodgement or migration, malfunction, and picc-associated thrombosis were recorded. line associated infection was the most common complication (17.2%)."
35875074,Non-O blood type_ group B,"meta-analysis of the studies showed that the risk of picc-associated vte was significantly higher in blood types a [odds ratio (or)=1.54, 95% ci=1.17-2.03), p=0.002], b (or=2.35, 95% ci=1.71-3.23, p<0.0001), and ab (or=2.55, 95% ci=1.68-3.88, p<0.0001) and lower in blood types o (or=0.58, 95% ci=0.45-0.74, p<0.0001). subgroup analysis based on ethnicity demonstrated that blood type o may be a genetic protective factor for picc-associated vte in asians. among caucasians, individuals with blood types b and ab have a higher risk of picc-associated vte. blood types a, b, and ab are risk factors for picc-associated vte in asians. conclusions: blood type o is associated with a decreased risk of picc-associated vte, especially in asian populations. moreover, blood types a, b, and ab are risk factors for picc-associated vte."
24268631,Cancer,"there was a statistically significantly higher thrombosis rate in patients with cancer (71.9% vs 66.7%, p = .002)."
24268631,PICC insertion procedure,all patients 18-90 years old requiring picc insertion were considered for the study. conclusions: this study showed a high incidence of thrombosis of peripheral veins used for picc insertion.
38072566,Chemotherapy,the majority of patients receiving chemotherapy undergo picc catheterization. participants with malignant tumors receiving chemotherapy who accepted picc insertion operation were randomly allocated to the aspirin treatment group (n = 235) or the control group (n = 246).
38072566,PICC insertion procedure,participants with malignant tumors receiving chemotherapy who accepted picc insertion operation were randomly allocated to the aspirin treatment group (n = 235) or the control group (n = 246).
38072566,PICC infection,"however, piccs are significantly associated with catheter related complications, including deep vein thrombosis, blood infection, fibrin sheath, catheter prolapse, catheter displacement and blockage."
34373674,Number of comorbidities/HTA/Hyperglycemia,"the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period. age, sex, and medical comorbidities were extracted from the emr. mann-whitney non-parametric tests, fisher's exact tests, chi-square tests, and cochran-mantel-haenszel (cmh) tests were used to determine associations with dvt events for those with piccs based on medical comorbidities, picc lumen size, team placing the picc, impact of implant removal, and protective effect of dvt chemoprophylaxis."
34373674,Surgery_type of surgery,"the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period. the results of this study should be of particular interest to surgeons who do not typically give dvt prophylaxis and plan to perform surgery on patients with chf, a history of a dvt, or plan to manipulate the intramedullary canal."
34373674,PICC infection,background: peripherally inserted central catheter (picc) placement is necessary for delivery of intravenous (iv) antibiotics to treat bone and soft tissue infections. the major objectives of this study are identifying the rate of upper extremity picc-associated dvts after orthopaedic procedures;which orthopaedic subspecialties are most likely to encounter an upper extremity picc-associated dvt?what surgeries or medical comorbidities are risk factors for upper extremity picc-associated dvts?does type of dvt chemoprophylaxis decrease the risk of an upper extremity picc-associated dvt? methods: a retrospective review of electronic medical records (emr) was performed to include all patients undergoing irrigation and debridement (i&d) for treatment of orthopaedic surgery-related infections over a 10-year period.
29615373,PICC indwelling time,"the picc indwelling time was statistically different between the group with successful catheter advancement (n = 36, success group) and the group with failed catheter advancement (n = 18, failure group; p = .007) with ipsilateral trimmed piccs."
26349890,Chemotherapy,"purpose: to identify clinical incidence, risk factors and treatment of peripherally inserted central venous catheters (piccs)-related upper extremity venous thrombosis (uevt) in breast cancer patients undergoing chemotherapy. methods: we performed a retrospective cohort study of breast cancer patients with picc insertion undergoing chemotherapy. results: a total of 568 breast cancer patients with picc undergoing chemotherapy were included, for a total of 54,769 catheter days; 8 patients (1.4%) developed picc-related uevt."
26349890,Cancer,"peripherally inserted central catheter-related vein thrombosis in breast cancer patients. purpose: to identify clinical incidence, risk factors and treatment of peripherally inserted central venous catheters (piccs)-related upper extremity venous thrombosis (uevt) in breast cancer patients undergoing chemotherapy. methods: we performed a retrospective cohort study of breast cancer patients with picc insertion undergoing chemotherapy. results: a total of 568 breast cancer patients with picc undergoing chemotherapy were included, for a total of 54,769 catheter days; 8 patients (1.4%) developed picc-related uevt. conclusions: metastasis and malposition were significant risk factors for picc-related uevt in breast cancer patients. in multivariable analysis, metastasis (p = 0.002) and malposition (p = 0.013) were shown to be significant risk factors for picc-related uevt."
26349890,PICC insertion procedure,"in multivariable analysis, metastasis (p = 0.002) and malposition (p = 0.013) were shown to be significant risk factors for picc-related uevt. conclusions: metastasis and malposition were significant risk factors for picc-related uevt in breast cancer patients. methods: we performed a retrospective cohort study of breast cancer patients with picc insertion undergoing chemotherapy."
33383236,Chemotherapy,"background: a peripherally inserted central catheter (picc) is often necessary for patients receiving chemotherapy, but there is a risk of picc-related venous thrombosis (vt). we sought to use the caprini thrombosis risk model and color doppler flow imaging for the dynamic monitoring of an eventual thrombosis in patients receiving chemotherapy."
33383236,Cancer,the caprini thrombosis risk model predicts the risk of peripherally inserted central catheter-related upper extremity venous thrombosis in patients with cancer. conclusions: the caprini score is an independent predictor of the development of picc-related vt in patients with cancer.
24612469,Two or more lumens,"on bivariate analysis, recent diagnosis of cancer, interventional radiology placement, chemotherapy administration, number of lumens and picc-gauge were associated with picc-dvt."
24612469,Chemotherapy,"on bivariate analysis, recent diagnosis of cancer, interventional radiology placement, chemotherapy administration, number of lumens and picc-gauge were associated with picc-dvt."
24612469,Cancer,"on bivariate analysis, recent diagnosis of cancer, interventional radiology placement, chemotherapy administration, number of lumens and picc-gauge were associated with picc-dvt. following multivariable adjustment, recent cancer diagnosis (or 1.95 [95% ci 1.01-3.76]) and picc gauge (hr 2.21 [95%ci 1.04-4.70] and hr 3.56 [95%ci 1.31-9.66] for 5-fr and 6-fr piccs, respectively) remained associated with thrombosis. conclusions: recent diagnosis of cancer and picc gauge are associated with picc-dvt. these findings have important clinical ramifications and suggest that placement of large gauge piccs or piccs in patients with cancer may provoke thrombosis."
24612469,Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h,"because piccs are also recognized risk factors for lower-extremity dvt, lower-extremity dvt occurring while the picc was in situ was included."
35236188,PICC infection,"central line-associated bloodstream infection (28.1%) and symptomatic deep vein thrombosis (20.7%) were the most common complications. the most reasons for piccs removal were occlusion (425, 12.9%) and exit-site infections (189, 5.8%)."
29408616,Age,"following adjustment, picc exchange was independently associated with twofold greater risk of thrombosis (hazard ratio [hr] 1.98; 95% confidence interval [ci], 1.37-2.85) vs no exchange."
34103988,Cancer,"the incidence, risk factors, and patterns of peripherally inserted central catheter-related venous thrombosis in cancer patients followed up by ultrasound. purpose: a peripherally inserted central catheter (picc) is associated with venous thromboembolism (vte) especially in patients suffering from cancer. we analyzed the incidence, risk factors, and patterns of picc-related vte in cancer patients. patients and methods: patients with cancer who underwent picc placement were evaluated retrospectively."
34103988,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"after adjustment of multivariable analysis, patients with picc-related vte were more likely to have a ratio of picc diameter:vein diameter >0.35 (adjusted or, 1.689; 95% ci, 1.023-2.789) and high level of triglycerides (1.561; 1.096-2.223). conclusion: the non-o blood group, larger ratio of picc diameter:vein diameter, and high level of triglycerides were significantly associated with picc-related vte."
29125332,Chemotherapy,"univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt."
29125332,Cancer,"univariate analysis adjusting for the clustered sample showed that having chemotherapy, two or more previous piccs, a larger catheter size, a diagnosis of cancer and having a blood group b were all associated with an increased risk of a vt. in the multivariate analysis, picc diameter, cancer diagnosis and blood group b were all independently associated with increased risk of vt. conclusion: patients undergoing picc insertion with a blood group b appear to have a higher risk of vt, independent of risks attached to the picc procedure and cancer diagnosis."
29125332,PICC insertion procedure,"a cohort of patients who underwent picc insertion from september 2010 to august 2014 were followed up for symptomatic vt presentations diagnosed by ultrasound. conclusion: patients undergoing picc insertion with a blood group b appear to have a higher risk of vt, independent of risks attached to the picc procedure and cancer diagnosis."
27078849,Cancer,"peripherally inserted central venous catheters (piccs) are widely used in cancer patients. the risk factors for deep vein thrombosis associated with the use of piccs in cancer patients are largely unexplored. this study aimed to investigate the incidence of picc-associated thrombosis in lymphoma compared with its incidences in other types of cancer. a total of 8028 adult cancer patients inserted with picc between june 2007 and june 2015 were included in this study. logistic analysis revealed that a lymphoma diagnosis was a risk factor for uedvt in cancer patients inserted with picc (or: 3.849, 95% ci: 2.334-6.347). high risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma. patients with lymphoma were more likely to have picc-uedvt than those with other types of malignancies (7.1% vs. patients with lymphoma may be more predisposed to developing picc-uedvt than those with other types of malignancies. identifying the mechanism underlying the relationship between picc-uedvt and lymphoma requires further study."
30632436,Two or more lumens,"the logistic regression results revealed that picc-related venous thrombosis was associated with a history of venous thrombosis (or, 6.745 [3.237–14.056]), number of lumens (or, 1.934 [1.362–2.572] and or, 3.762 [1.672–5.932] for dual and triple lumens, respectively), and picc gauge (or, 1.821 [1.256–2.537] and or, 3.864 [1.367–8.251] for 5-fr and 6-fr, respectively). conclusions: a history of thrombosis, high number of lumens, and large-gauge catheters were strong risk factors for patients aged >65 years undergoing picc placement."
30632436,Age,objective: this study was performed to determine the risk factors associated with peripherally inserted central catheter (picc)-related venous thrombosis in patients of advanced age (>65 years).
30632436,History Of Thrombosis,"conclusions: a history of thrombosis, high number of lumens, and large-gauge catheters were strong risk factors for patients aged >65 years undergoing picc placement."
34498477,PICC insertion procedure,"a comparative study on the tip position of peripherally inserted central catheter inserted at two forward p-wave amplitudes by intracavitary electrocardiogram in cancer patients. for the observation group, the position of the catheter tip was left at the level when p wave amplitude was its autonomous peak (168 patients catheterized in 2018). the total compliance rate [picc tip was located in the lower third of the superior vena cava (svc) and the cavo-atrial junction (caj)], the optimal position compliance rate (picc tip was located in the caj), and the incidence of the catheter tip malposition were compared between the two groups. results: there was no difference in the total compliance rate of picc tip position and the incidence of the catheter malposition in the two groups (p>0.05). but the optimal position compliance rate of the observation group was higher than that of the control group (p<0.05). conclusions: the picc tip position at the autonomous peak of the p wave is significantly better than that at the p wave amplitude being 50-80% of the qrs main wave under the ic-ekg guidance for picc insertion. methods: the data of 300 cancer patients with picc insertion were collected retrospectively."
34498477,PICC infection,"the complications after catheterization including arrhythmia after catheterization within 24 hours, catheter-related thrombosis, catheter dysfunction, and catheter infection within 90 days were also compared. the incidence of catheter-related thrombosis, catheter dysfunction, and catheter infection within 90 days in the observation group was lower than those in the control group (p<0.05)."
33836784,PICC insertion procedure,"ledvt-related factors and d-dimer value were analyzed before and after picc insertion. results: univariate logistic regression analysis showed that picc insertion increased the risk of ledvt by 9 times and promoted the increase of d-dimer by 5 times. after risk adjustment, multivariate logistic regression analysis showed that picc insertion increased the risk of ledvt by 4 times and tripled the risk of d-dimer increase. the concentration of d-dimer was significantly increased after picc insertion. conclusions: picc insertion increases the level of d-dimer and the risk of ledvt."
32928286,PICC infection,"secondary outcomes were central line-associated bloodstream infection, local infection, occlusion, thrombosis, fracture and dislodgement, phlebitis, local or systemic allergic reaction, and picc dwell time."
25295962,Two or more lumens,"however, univariate analysis revealed that insertion of a 4f sl picc instead of either 5f double lumen or 6f triple lumen was associated with a reduction in picc-associated dvt (p = 0.001). after the qi intervention, 4f sl catheter insertion substantially increased to 65.8% of all piccs inserted, whereas 6f triple-lumen catheter insertion declined to 6.8% of piccs inserted."
25295962,Age,methods: this was a 5-year retrospective cohort study with subsequent 21-month prospective observation following implementation of a qi intervention in adults (aged 18 yr or older) with cf.
25295962,PICC insertion procedure,"picc insertions were analyzed, and nine risk factors for dvt were analyzed to formulate a qi initiative to reduce risk of picc-associated dvt. zero episodes of dvt associated with 4f picc insertion prevented use of picc size in regression analysis."
34107707,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"the incidence of infection and the differences in saa, pct, crp, prothrombin time (pt), activated partial thromboplastin time (aptt), thrombin time (tt), fibrinogen (fig), interleukin-18 (il-18), and interleukin-16 (il-6) between the infected group and noninfected group were observed."
34107707,PICC infection,"analysis of the relationship between serum amyloid protein a, procalcitonin, c-reactive protein, and peripherally inserted central catheter infection in patients with malignant tumor. background: compared with a central venous catheter, a peripherally inserted central catheter (picc) has the advantages of less trauma and a lower risk of bleeding and bloodstream infection. however, patients with tumors are commonly immunocompromised and therefore susceptible to infection during the course of picc indwelling. this study aimed to investigate the relationship between serum amyloid protein a (saa), procalcitonin (pct), c-reactive protein (crp), and picc infection in patients with malignant tumor. the incidence of infection and the differences in saa, pct, crp, prothrombin time (pt), activated partial thromboplastin time (aptt), thrombin time (tt), fibrinogen (fig), interleukin-18 (il-18), and interleukin-16 (il-6) between the infected group and noninfected group were observed. the correlations of saa, pct, and crp levels in different infection sites and infection degrees were analyzed. results: a total of 414 eligible patients were included with 93 in the infection group and 321 in the noninfection group. the overall incidence of infection was 22.4%. the levels of saa, pct and crp in the infection group were significantly higher than those in the noninfection group (p<0.001). compared with the local infection group, the levels of saa, pct, and crp in the bloodstream infection group were significantly higher (p<0.001). furthermore, the levels of saa, pct, and crp were positively correlated with the degree of picc catheter infection. conclusions: in patients with malignant tumors, picc catheter infection were associated with increased risk of bleeding and the levels of saa, pct, and crp can be used as predictive diagnostic indexes for picc catheter infection. furthermore, these parameters were positively correlated with the degree of picc catheter infection."
37070255,PICC indwelling time,"there was no significant intergroup difference in the overall rate of catheter-related complications (picc: 9.4% vs cicc: 3.8%; odds ratio [or]: 2.65; 95% confidence interval [ci]: 0.63-10.2, p = 0.145), and there were 7.7 and 9.0 complications per 1000 catheter days in the picc and cicc groups, respectively (hazard ratio [hr]: 0.61; 95% ci: 0.14-2.65, p = 0.513)."
25501778,PICC infection,"four cases of symptomatic upper extremity deep vein thrombosis (5.5%) and three cases of central line-associated bloodstream infection (4.3%, 2.72 infections per 1000 line days) were identified."
24439240,Total parenteral nutrition,a comparative study of peripherally-inserted and broviac catheter complications in home parenteral nutrition patients. background & aims: peripherally inserted central venous catheters (picc) have become increasingly popular for medium to long-term parenteral nutrition (pn) but there is limited data on the complication rates in this sub-group.
24439240,PICC infection,"catheter infection rate was lower in picc (1.87 vs. however, the broviac catheter could be associated with an increase in catheter infection."
23876203,PICC infection,the overall infection rate was 2.3 per 1000 catheter-days with 0.86 per 1000 catheter-days for central line-associated bloodstream infection.
25935657,Chemotherapy,"however, there are few studies on use of piccs in patients with haematological malignancies (hm) receiving intensive chemotherapy. conclusions: this study highlights the utility of a multidisciplinary approach for picc care in adults with hm receiving intensive chemotherapy."
28149507,Age,"occlusion and accidental withdrawal were the most common complications, with age > 65 and catheter pre-occlusive event associated with an increased likelihood of catheter occlusion."
30755503,Chemotherapy,"can peripherally inserted central catheters be safely placed in patients with cancer receiving chemotherapy? a retrospective study of almost 400,000 catheter-days. background: peripherally inserted central catheters (piccs) are central venous catheters (cvcs) that are commonly used in onco-hematologic settings for chemotherapy administration. as there is insufficient evidence to recommend a specific cvc for chemotherapy administration, we aimed to ascertain picc-related adverse events (aes) and identify independent predictors of picc removal in patients with cancer receiving chemotherapy. materials and methods: information on adult patients with cancer with a picc inserted for chemotherapy administration between september 2007 and december 2014 was extracted from six hospital databases. conclusion: use of picc for chemotherapy administration was associated with a low all-aes rate. implications for practice: these findings provide clinicians with evidence that peripherally inserted central catheters (piccs) are safe for chemotherapy administration. they also suggest that clinicians should limit the use of open systems when long chemotherapy regimens are scheduled. moreover, alternatives to piccs should be considered when administering chemotherapy to young men."
30755503,Gender,"more research is needed to explore the interaction between aes, sex, and age."
30755503,Age,"aes increased when picc was inserted at the brachial site (hazard ratio [hr], 1.37; 95% confidence interval [ci], 1.02-1.84) and with open systems (hr, 1.89; 95% ci, 1.24-2.88) and decreased in older men (hr, 0.63; 95% ci, 0.49-0.81). moreover, alternatives to piccs should be considered when administering chemotherapy to young men."
25673995,Chemotherapy,"background: peripherally inserted central catheters (piccs) are widely used in chemotherapy, but the reported picc thrombosis incidence varies greatly, and risks of picc thrombosis are not well defined. the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis."
25673995,Cancer,peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation. this study was to investigate the incidence and risk factors of picc-related upper extremity vein thrombosis in cancer patients. cancer patients who were subject to picc placement were enrolled and checked by doppler ultrasound weekly for at least 1 month. results: three hundred and eleven cancer patients were enrolled in the study.
25673995,BMI,"the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis. multivariate analysis showed that less activity (or 9.583, p=0.000) and obesity (or 3.466, p=0.014) were significantly associated with picc thrombosis. less activity and obesity are risk factors of picc-related thrombosis."
25673995,Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h,"the univariable logistic regression analysis showed that complications (odds ratio [or] 1.686, p=0.032), less activity (or 1.476, p=0.006), obesity (or 3.148, p=0.000), and chemotherapy history (or 3.405, p=0.030) were associated with picc thrombosis. multivariate analysis showed that less activity (or 9.583, p=0.000) and obesity (or 3.466, p=0.014) were significantly associated with picc thrombosis. less activity and obesity are risk factors of picc-related thrombosis."
23440314,Cancer,"peripherally inserted central catheter placement in cancer patients with profound thrombocytopaenia: a prospective analysis. we prospectively determined the frequency of haemorrhagic complications of picc placement in cancer patients with uncorrected profound thrombocytopaenia. results: one hundred and forty-three picc implantations in 101 cancer patients were prospectively included in the study: seven patients (7 %) had a solid tumour and 94 (93 %) a haematological malignancy. conclusions: in cancer patients with uncorrected profound thrombocytopaenia, the incidence of adverse events after picc implantation was low, and was limited to minor haemorrhagic adverse events. key points: • picc placement has high technical success in profound thrombocytopaenic cancer patients."
23440314,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"methods: profound thrombocytopaenia was defined as a platelet count <50 × 10(9)/l. among these 143 procedures in thrombocytopaenic patients, 93 (65 %) were performed with a platelet count 20-50 × 10(9)/l and 50 (35 %) had lower than 20 × 10(9)/l. in patients with a platelet count <20 × 10(9)/l, 1/50 (2 %) had minor oozing and none had minor haematoma. • picc placement does not routinely require platelet transfusion in patients with thrombocytopaenia. • such picc placement still seems safe when the platelet count is <20 × 10 (9) /l."
27978519,PICC insertion procedure,"methods: twenty-five als patients in the later stages of the disease underwent picc insertion followed by parenteral nutrition (pn). results: picc insertion was successful in all patients. conclusion: picc insertion for pn at a later stage of als, in patients for whom gastrostomy is non-feasible, appears to be a useful option compared to the central venous catheter."
27978519,Total parenteral nutrition,methods: twenty-five als patients in the later stages of the disease underwent picc insertion followed by parenteral nutrition (pn).
29872323,Cancer,"patients and methods: this was a retrospective cohort study of npc patients with picc insertions from february 2, 2007 to december 25, 2014 in sun yat-sen university cancer centre. the incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma. background: despite wide usage, peripherally inserted central catheter (picc)-related venous thromboembolism (vte) is common in nasopharyngeal carcinoma (npc) patients. in univariable analysis, body mass index (bmi), eastern cooperative oncology group (ecog) score, metastasis stage (m stage), and vte history were associated with symptomatic picc-vte."
29872323,BMI,"in univariable analysis, body mass index (bmi), eastern cooperative oncology group (ecog) score, metastasis stage (m stage), and vte history were associated with symptomatic picc-vte. following multivariable adjustments, bmi (or 0.900, p=0.007), ecog score (or 4.162, p=0.011), m stage (or 2.717, p=0.019), and vte history (or 109.772, p<0.001) were still statistically significant. those with vte history and lower bmi and worse ecog performance score metastatic npc patients are more susceptible to symptomatic picc-related thrombosis and thus may require prophylactic anticoagulation."
29872323,Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h,"those with vte history and lower bmi and worse ecog performance score metastatic npc patients are more susceptible to symptomatic picc-related thrombosis and thus may require prophylactic anticoagulation. in univariable analysis, body mass index (bmi), eastern cooperative oncology group (ecog) score, metastasis stage (m stage), and vte history were associated with symptomatic picc-vte. following multivariable adjustments, bmi (or 0.900, p=0.007), ecog score (or 4.162, p=0.011), m stage (or 2.717, p=0.019), and vte history (or 109.772, p<0.001) were still statistically significant."
25664112,BMI,"the medical information of 159 patients (age, body mass index (bmi), diagnosis, smoking history, nutritional risk score, platelet count, leucocyte count as well as levels of d-dimer, fibrinogen, and degradation products of fibrin) were collected."
25664112,Smoking,"the medical information of 159 patients (age, body mass index (bmi), diagnosis, smoking history, nutritional risk score, platelet count, leucocyte count as well as levels of d-dimer, fibrinogen, and degradation products of fibrin) were collected."
25664112,Number of comorbidities/HTA/Hyperglycemia,"being bedridden for a long time (odds ratio [(or]), 17.774; p=0.0017), d-dimer >5 mg/l (36.651; 0.0025) and suffering from one comorbidity (8.39; 0.0265) or more comorbidities (13.705; 0.0083) were the major risk factors for picc-catheter related venous thrombosis by stepwise logistic regression analysis. being bedridden >72 h, having increased levels of d-dimer (>5 mg/l) and suffering from comorbidities were independent risk factors of picc-related venous thrombosis."
25664112,Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h,"being bedridden for a long time (odds ratio [(or]), 17.774; p=0.0017), d-dimer >5 mg/l (36.651; 0.0025) and suffering from one comorbidity (8.39; 0.0265) or more comorbidities (13.705; 0.0083) were the major risk factors for picc-catheter related venous thrombosis by stepwise logistic regression analysis. being bedridden >72 h, having increased levels of d-dimer (>5 mg/l) and suffering from comorbidities were independent risk factors of picc-related venous thrombosis."
25664112,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"the medical information of 159 patients (age, body mass index (bmi), diagnosis, smoking history, nutritional risk score, platelet count, leucocyte count as well as levels of d-dimer, fibrinogen, and degradation products of fibrin) were collected."
27033138,Two or more lumens,"limiting the number of lumens in peripherally inserted central catheters to improve outcomes and reduce cost: a simulation study. background the number of peripherally inserted central catheter (picc) lumens is associated with thrombotic and infectious complications. conclusion hospital policies that limit the number of picc lumens may enhance patient safety and reduce healthcare costs. because multilumen piccs are not necessary in all patients, policies that limit their use may improve safety and cost. methods model inputs, including risk of complications and costs associated with single- and multilumen piccs, were obtained from available literature and a multihospital collaborative quality improvement project. results according to our model, a hospital that places 1,000 piccs per year (25% of which are single-lumen and 75% multilumen) experiences annual picc-related maintenance and complication costs of $1,228,598 (95% ci, $1,053,175-$1,430,958)."
27033138,PICC infection,"cost savings and reduction in central line-associated bloodstream infection and deep vein thrombosis events from institution of a single-lumen picc default policy were reported. in such facilities, every 5% increase in single-lumen picc use would prevent 0.5 picc-related central line-associated bloodstream infections and 0.5 picc-related deep vein thrombosis events, while saving $23,500."
24246096,Cancer,"five baseline exposure factors, including primary lung cancer, metastatic lung cancer, chest radiotherapy, vigorous coughing and severe vomiting, were significant risk factors of picc spontaneous dislodgment."
27179394,PICC indwelling time,"results: significant outcomes included a central-line associated blood stream infection rate that changed from 1.38/1,000 catheter days to 0/1,000 catheter days, 0 provider-led premature picc removals, an overall 84% decrease in premature picc removals (from 16%-2.5%; p < .0001), a decrease in the total complication rate from 45.5%-24% (p < .0001), and 25% reduction in radiology costs."
27179394,PICC infection,"a novel infection prevention approach: leveraging a mandatory electronic communication tool to decrease peripherally inserted central catheter infections, complications, and cost. background: peripherally inserted central catheters (piccs) removed prematurely for unconfirmed infection or thrombosis lead to subsequent reinsertions and associated complications. results: significant outcomes included a central-line associated blood stream infection rate that changed from 1.38/1,000 catheter days to 0/1,000 catheter days, 0 provider-led premature picc removals, an overall 84% decrease in premature picc removals (from 16%-2.5%; p < .0001), a decrease in the total complication rate from 45.5%-24% (p < .0001), and 25% reduction in radiology costs. conclusion: a novel infection prevention approach leveraging a mect resulted in 0 central line-associated bloodstream infections and provider-led premature picc removals."
24954426,ICU,"picc aes accounted for increased intensive care unit admissions, ht list inactivations, and overall cost."
24954426,Transplantation,are peripherally inserted central catheters associated with increased risk of adverse events in status 1b patients awaiting transplantation on continuous intravenous milrinone? . background: peripherally inserted central catheters (piccs) are used to deliver continuous intravenous (iv) milrinone in stage d heart failure (hf) patients awaiting heart transplantation (ht).
24954426,PICC infection,"results: fifty-three picc aes occurred in 35 patients (27%), consisting of 48 infections, 4 thromboses, and 1 bleeding event. median duration of picc support was 63 (interquartile range [iqr] 34-131) days, and median time to first picc infection was 44 (iqr 14-76) days. among picc infections, 9% required defibrillator removal and 30% were inactivated on the ht list for a mean of 23 ± 17 days. regression analysis found that a double lumen picc was associated with a shorter time to first picc infection (hazard ratio 7.59, 95% ci 1.97-29.23; p = .003). median cost per picc infection was $10,704 (iqr $7,401-$26,083). conclusions: picc infections were the most frequent aes. piccs with >1 lumen were associated with increased risk of infection."
23838218,Two or more lumens,"immunosuppression (p<.01), power-injectable piccs (p=.05), and 3 picc lumens compared with 1 lumen (p=.02) were associated with clabsi. conclusions: immunosuppression and 3 picc lumens were associated with increased risk of clabsi."
23838218,Power injectable PICC,"immunosuppression (p<.01), power-injectable piccs (p=.05), and 3 picc lumens compared with 1 lumen (p=.02) were associated with clabsi. power-injectable piccs were also associated with increased vt formation (p=.03). power-injectable piccs were associated with increased risk of clabsi and vt formation."
23838218,Immunosuppression,"immunosuppression (p<.01), power-injectable piccs (p=.05), and 3 picc lumens compared with 1 lumen (p=.02) were associated with clabsi. conclusions: immunosuppression and 3 picc lumens were associated with increased risk of clabsi."
23838218,PICC insertion procedure,"objective: peripherally inserted central catheter (picc) tip malposition is potentially associated with complications, and postplacement adjustment of piccs is widely performed."
23838218,PICC infection,impact of postplacement adjustment of peripherally inserted central catheters on the risk of bloodstream infection and venous thrombus formation. we sought to characterize the association between central line-associated bloodstream infection (clabsi) or venous thrombus (vt) and picc adjustment.
24005884,Chemotherapy,"comparison of peripherally inserted central venous catheters (picc) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies. purpose: indwelling central venous catheters (cvcs) have been increasingly used to enable delivery of intravenous chemotherapy. we aimed to compare the safety and cost of two commonly used cvcs, peripherally inserted central venous catheter (piccs) and ports, in the delivery of chemotherapy in patients with non-haematological malignancies. conclusions: port devices are associated with a lower risk of complications, with no difference in cost, compared to picc lines in patients with non-haematological malignancies receiving intravenous chemotherapy."
24005884,PICC indwelling time,"major complication rate was lower in the port arm compared to the picc arm (0.047 versus 0.193 major complications/100 catheter days, p = 0.034) with 6 versus 20 % of patients experiencing major complications, respectively."
27895356,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"the level of blood platelet (plt) count, prothrombin activity (pta) and white blood cell (wbc) count before venous catheterisation were independent risk factors for bleeding at the puncture site and catheter-related infections."
27895356,PICC infection,"the level of blood platelet (plt) count, prothrombin activity (pta) and white blood cell (wbc) count before venous catheterisation were independent risk factors for bleeding at the puncture site and catheter-related infections."
31970514,PICC infection,"severe bloodstream infections occurred at a rate of 0.60 per 1000 catheter days (n = 11, 2.1%), deep vein thrombosis at a rate of 0.82 per 1.000 catheter days (n = 15, 2.9%) and local inflammation at a rate of 1.26 per 1.000 catheter days (n = 23, 4.4%). particular attention should be payed to early identification of picc associated bloodstream infections."
30704933,Chemotherapy,"a frontline approach with peripherally inserted versus centrally inserted central venous catheters for remission induction chemotherapy phase of acute myeloid leukemia: a randomized comparison. thereafter, all patients underwent intensive chemotherapy for hematologic remission induction. the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days."
30704933,Age,"the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days."
30704933,PICC infection,"the primary endpoint was catheter-related (cr)-bloodstream infection (bsi) and venous thrombosis (vt) rate. using piccs, the reduction in bsi and symptomatic vt decreased mortality from cr infection and venous thromboembolism. the use of a picc is safer than that of a cicc and maintains the effectiveness for patients with aml undergoing chemotherapy, with an approximate fourfold lower combined risk of infection or thrombosis at 30 days."
34432170,Cancer,"a model to assess the risk of peripherally inserted central venous catheter-related thrombosis in patients with breast cancer: a retrospective cohort study. purpose: limited risk assessment tool to stratify the risk of picc-related thrombosis (picc-rvt) in breast cancer patients. this study developed a model to assess the risk of picc-rvt in breast cancer patients. methods: we conducted a retrospective cohort study of 1284 breast cancer patients receiving picc insertion from january 1, 2015, to august 31, 2019, at a cancer specialized hospital in hunan province, china. conclusion: several disease-specific factors of breast cancer (e.g., menopause, endocrine therapy, and upper extremity lymphedema) play important roles in the development of picc-rvt."
34432170,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy."
34432170,Surgery_type of surgery,"multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy."
34432170,Menopause_endocrine therapy_hormone use,"multivariable analysis identified 9 variables: chronic obstructive pulmonary disease, prior central venous catheter placement, higher level of platelets, higher level of d-dimer, lower level of activated partial thromboplastin time, menopause, no prior breast surgery, upper extremity lymphedema, and endocrine therapy. conclusion: several disease-specific factors of breast cancer (e.g., menopause, endocrine therapy, and upper extremity lymphedema) play important roles in the development of picc-rvt."
27542955,Cancer,"the prevalence and incidence rates of crt in our al patients were higher than predicted for a general cancer patient population. incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. concomitant severe thrombocytopenia makes anticoagulation for catheter-related thrombosis (crt) in patients with acute leukemia (al) a challenge. our objective is to compare the incidence rate of crt in leukemia inpatients who received either a picc vs."
27542955,PICC indwelling time,"the incidence rates were 1.89 and 0.52 per 1000 catheter day in the picc and cicc groups, respectively."
27020965,Chemotherapy,"peripherally inserted central catheters (piccs) in cancer patients under chemotherapy: a prospective study on the incidence of complications and overall failures. background and objectives: the increasing use of peripherally inserted central venous catheters (piccs) for chemotherapy has led to the observation of an elevated risk of complications and failures. methods: a prospective study was conducted at a single cancer institution on 291 picc placement for chemotherapy. statistically significant risk factors were previous dvt (hr 2.95, 95%ci 1.33-6.53), reason for picc implant (hr 3.65, 95%ci 1.12-10.34) and 5-fluorouracil, oxaliplatin and bevacizumab based chemotherapy (hr 3.11, 95%ci 1.17-8.26). conclusions: picc is a safe venous device for chemotherapy delivery. nevertheless, a 15% rate of failure has to be taken in account when planning picc insertion for chemotherapy purposes."
27020965,PICC insertion procedure,"nevertheless, a 15% rate of failure has to be taken in account when planning picc insertion for chemotherapy purposes."
27020965,PICC indwelling time,"reasons for failures were upper extremity deep venous thrombosis (uedvt) 12 (4.1%), central line associate bloodstream infection (clabsi) 5 (1.7%) with an infection rate of 0.95 per 1,000 catheter days, exit site infection 9 (3.1%) with a rate of 1.46 per 1,000 catheter days, catheter dislodgment 11 (3.8%), and occlusion 7 (2.4%)."
27020965,PICC infection,"reasons for failures were upper extremity deep venous thrombosis (uedvt) 12 (4.1%), central line associate bloodstream infection (clabsi) 5 (1.7%) with an infection rate of 0.95 per 1,000 catheter days, exit site infection 9 (3.1%) with a rate of 1.46 per 1,000 catheter days, catheter dislodgment 11 (3.8%), and occlusion 7 (2.4%)."
35034480,Cancer,"a previous report on breast cancer patients demonstrated the safety and efficacy of these devices, with a very low failure rate."
33893843,Chemotherapy,"however, patients with higher caprini scores and higher fibrinogen levels are at increased risk for picc-rvt, as are patients receiving chemotherapy."
33893843,Cancer,plasminogen activator inhibitor-1 gene promoter 4g/5g polymorphism and risks of peripherally inserted central catheter-related venous thrombosis in patients with lung cancer: a prospective cohort study. purpose: this study investigated the influence of plasminogen activator inhibitor-1 (pai-1) gene polymorphisms and other contributing clinical factors on peripherally inserted central catheter-related venous thrombosis (picc-rvt) in chinese patients with lung cancer. conclusion: our finding suggested that there is no statistically significant influence of the pai-1 4g/5g gene variant on picc-rvt in chinese patients with lung cancer.
33893843,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"a higher fibrinogen level (or 1.194, 95% ci 1.004-1.420, p = 0.045) and a higher caprini score (or 1.698, 95% ci 1.103-2.614, p = 0.016) were statistically significant risk factors for picc-rvt. however, patients with higher caprini scores and higher fibrinogen levels are at increased risk for picc-rvt, as are patients receiving chemotherapy."
34673343,PICC infection,"after a median follow-up of 334 [130-798] days, there were no differences in the rates of local (0.22 vs 0.21; p = 0.904) or blood-stream infections (0.13 vs 0.21; p = 0.405)."
34673343,Hypertension,complications associated with peripherally inserted central catheters and hickman™ in patients with advanced pulmonary hypertension treated with intravenous prostanoids. evidence regarding the comparison between peripherally inserted central catheters (picc) or tunneled central catheters in pulmonary hypertension (ph) is scarce.
36726149,Cancer,"efficacy and safety of rivaroxaban for the treatment of picc-related upper extremity deep vein thrombosis in cancer patients: a retrospective study. background: the optimal duration and choice of anticoagulant for the treatment of peripherally inserted central catheters (picc)-related upper extremity deep vein thrombosis (uedvt) in cancer patients are still undetermined. objectives: the aim of this study was to assess the efficacy and safety of rivaroxaban for the treatment of picc-related uedvt in cancer patients. methods: we conducted a retrospective cohort study including consecutive cancer patients for the management of acute symptomatic picc-related uedvt. conclusion: our study supported the efficacy of rivaroxaban for treating picc-related uedvt in cancer patients. considering the risk-benefit ratio, further well-designed trials are required to optimize the drug selection and duration for the treatment of picc-related uedvt in cancer patients."
31948240,Chemotherapy,permanent venous access devices allow the application of chemotherapy and repeated blood sample collections with minimal impact on the quality of life in cancer patients.
31948240,Cancer,"venous access in cancer patients. the most commonly used permanent venous access devices in cancer patients are the port, picc port and picc catheter (peripherally inserted central catheter). it is always necessary to consider the type of venous access needed for each individual cancer patient. permanent venous access devices allow the application of chemotherapy and repeated blood sample collections with minimal impact on the quality of life in cancer patients."
32572092,Cancer,a longitudinal observational retrospective study on risk factors and predictive model of picc associated thrombosis in cancer patients.
32572092,Gender,"tumor, sex, age, weight, height, bmi, bsa, ps, wbc, bpc, pt, d-dimer, aptt, fib, smoking history, location, catheter length, ratio and number as independent variables were analyzed by fisher's scoring, then logistic risk regression, roc analysis and nomogram was introduced."
32572092,BMI,"tumor, sex, age, weight, height, bmi, bsa, ps, wbc, bpc, pt, d-dimer, aptt, fib, smoking history, location, catheter length, ratio and number as independent variables were analyzed by fisher's scoring, then logistic risk regression, roc analysis and nomogram was introduced."
32572092,Smoking,"tumor, sex, age, weight, height, bmi, bsa, ps, wbc, bpc, pt, d-dimer, aptt, fib, smoking history, location, catheter length, ratio and number as independent variables were analyzed by fisher's scoring, then logistic risk regression, roc analysis and nomogram was introduced."
26202391,Chemotherapy,"multivariate logistic regression analysis showed a higher picc-related infection rate with chemotherapy (odds ratio (or) 7.2-confidence interval (ci) 95% [1.77-29.5]), auto/allograft (or 5.9-ci 95% [1.2-29.2]), and anti-coagulant therapy (or 2.2-95% [1.4-12]). conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections. clinical advance: chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of picc-associated infections."
26202391,PICC infection,"peripherally inserted central catheter-related infections in a cohort of hospitalized adult patients. all picc-related infections were recorded and categorized as catheter-related bloodstream infections (cr-bsi), exit-site infections, and septic thrombophlebitis. 31 (3.4%) picc-related infections occurred during the study period corresponding to an infection rate of 1.64 per 1000 catheter-days. we observed 27 (87.1%) cr-bsi, corresponding to a rate of 1.43 per 1000 catheter-days, 3 (9.7%) septic thrombophlebitis, and 1 (3.2%) exit-site infection. multivariate logistic regression analysis showed a higher picc-related infection rate with chemotherapy (odds ratio (or) 7.2-confidence interval (ci) 95% [1.77-29.5]), auto/allograft (or 5.9-ci 95% [1.2-29.2]), and anti-coagulant therapy (or 2.2-95% [1.4-12]). conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections. clinical advance: chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of picc-associated infections. a careful assessment of these risk factors may be important for future success in preventing picc-related infections."
26202391,Anticoagulants therapy,"multivariate logistic regression analysis showed a higher picc-related infection rate with chemotherapy (odds ratio (or) 7.2-confidence interval (ci) 95% [1.77-29.5]), auto/allograft (or 5.9-ci 95% [1.2-29.2]), and anti-coagulant therapy (or 2.2-95% [1.4-12]). conclusion: chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing picc-related infections. clinical advance: chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of picc-associated infections."
35943390,Chemotherapy,the most common indications for picc use were antibiotics (34.5%) and difficult access or blood draws (21.6%); chemotherapy was the primary indication in only 15.7% of patients. conclusions: piccs were associated with significant complications in hospitalized patients who had solid malignancies and were often used for reasons other than chemotherapy.
35943390,PICC infection,"major complications were defined as central line-associated bloodstream infection, deep vein thrombosis, pulmonary embolism, and catheter occlusion. a major picc-related complication occurred in 491 patients (15.2%); catheter occlusion was the most prevalent complication (n = 322; 10.0%) followed by deep vein thrombosis (n = 116; 3.6%), central line-associated bloodstream infection (n = 82; 2.5%), and pulmonary embolism (n = 20; 0.6%). overall, 15.2% of patients experienced a complication, including central line-associated bloodstream infections, deep vein thrombosis, pulmonary embolism, or catheter occlusion."
35763062,Age,"lowering platelet count threshold to 10,000/µl for peripherally inserted central catheter placement safely conserves blood products. we assessed the impact of lowering prophylactic platelet administration threshold on blood product utilization patterns and bleeding events. the study population included patients with platelet counts ≥ 10,000/µl and < 50,000/µl undergoing picc placement in 2018 and 2019 when the minimum platelet thresholds were 50,000/µl and 10,000/µl, respectively. thirty-five patients using the 10,000/µl (10 k) platelet threshold and 46 patients using the 50,000/µl (50 k) platelet threshold were enrolled. lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding."
35763062,PICC insertion procedure,"the primary outcome was blood product utilization and the secondary outcome was picc insertion-related bleeding complications. the 50 k group received more platelets before picc insertion (0.870 ± 0.885 and 0.143 ± 0.430 pools of platelets-per-person, p < 0.001). immediately following picc insertion, minor bleeding occurred in five patients (two [4.3%] and three [8.6%] in the 50 k and 10 k groups, respectively). lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding."
35763062,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"lowering platelet count threshold to 10,000/µl for peripherally inserted central catheter placement safely conserves blood products. despite the low risk of peripherally inserted central catheter (picc) insertion-related bleeding, the practice of administering prophylactic platelets varies greatly. we assessed the impact of lowering prophylactic platelet administration threshold on blood product utilization patterns and bleeding events. the study population included patients with platelet counts ≥ 10,000/µl and < 50,000/µl undergoing picc placement in 2018 and 2019 when the minimum platelet thresholds were 50,000/µl and 10,000/µl, respectively. thirty-five patients using the 10,000/µl (10 k) platelet threshold and 46 patients using the 50,000/µl (50 k) platelet threshold were enrolled. the 50 k group received more platelets before picc insertion (0.870 ± 0.885 and 0.143 ± 0.430 pools of platelets-per-person, p < 0.001). lowering the minimum platelet threshold from 50,000/µl to 10,000/µl resulted in less prophylactic platelet and total blood product administration with no appreciable difference in picc insertion-related bleeding."
27818170,ICU,"methods: we implemented a prospective study between jan 1, 2013, and sept 12, 2015, in patients (age ≥18 years) admitted to a general medicine ward or intensive care unit who received a picc for any reason during clinical care in 47 hospitals in michigan, usa, with a maximum follow-up of 70 days."
27818170,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"association between delivery methods for red blood cell transfusion and the risk of venous thromboembolism: a longitudinal study. background: mechanisms of red blood cell delivery and their contribution to the incidence of venous thromboembolism are not well understood in the clinical setting. we assessed whether red blood cell transfusion through peripherally inserted central catheters (piccs) affects the risk of venous thromboembolism compared with transfusion through non-picc devices. the exposure of interest was route of red blood cell transfusion. of 788 patients who received a red blood cell transfusion through a multi-lumen picc, 61 had venous thromboembolism. for every red blood cell unit transfused through a picc, there was a significantly increased risk of venous thromboembolism (adjusted hr 1·24, 95% ci 1·01-1·52; p=0·037). interpretation: red blood cell delivery through a multi-lumen picc is associated with a greater risk of thrombosis than transfusion through a peripheral intravenous catheter. careful monitoring for venous thromboembolism when transfusing red blood cells through multi-lumen piccs seems necessary."
30673943,Chemotherapy,"patients treated with picc removal alone were more likely to have hematologic malignancy, receive chemotherapy, develop thrombocytopenia, and have brachial vein thrombosis."
30673943,Cancer,"patients treated with picc removal alone were more likely to have hematologic malignancy, receive chemotherapy, develop thrombocytopenia, and have brachial vein thrombosis."
36853924,Cancer,clinical study of complications of a peripherally inserted central catheter in cancer patients. aim: to evaluate complications after picc use in cancer patients. this study demonstrated the effectiveness of picc and that patients with haematological cancer are more prone to multiple picc passages and more mechanical complications and infections.
36853924,PICC infection,"the most common complications were mechanical complications (61.2%), infection (38%), and thrombosis (57.1%). this study demonstrated the effectiveness of picc and that patients with haematological cancer are more prone to multiple picc passages and more mechanical complications and infections."
33860712,Age,the incidences of picc-uevt were 4.5% for d-dimer above the age-adjusted threshold and 1.5% for below the threshold (p = 0.001).
33860712,PICC indwelling time,"validation of michigan risk score and d-dimer to predict peripherally inserted central catheter-related thrombosis: a study of 206,132 catheter days. results: two thousand one hundred sixty-three patients were included for a total of 206,132 catheter days."
26117624,PICC insertion procedure,the same vein entry site was used for placement of the ivcf followed by picc insertion. conclusion: simultaneous ivcf and picc insertion using the same upper extremity venous access was feasible and safe in our series.
25997503,Total parenteral nutrition,"univariate and multivariate analysis demonstrated a history of transplant, and the indication of total parenteral nutrition was associated with thrombosis (p<0.001)."
32709498,ICU,peripherally inserted central catheter lines for intensive care unit and onco-hematologic patients: a systematic review and meta-analysis. objective: to compare central line associated bloodstream infection (clabsi) and catheter-related thrombosis rates in intensive care unit (icu) and onco-hematologic patients with picc lines and cvcs.
32709498,PICC infection,objective: to compare central line associated bloodstream infection (clabsi) and catheter-related thrombosis rates in intensive care unit (icu) and onco-hematologic patients with picc lines and cvcs.
34459038,PICC infection,"the insertion-site blood oozing and central line-associated bloodstream infection rates were 36.5% (19/52) and 26.9% (14/52), respectively, indicating the feasibility of these piccs for various applications in allo-hsct."
34343193,PICC insertion procedure,"the pooled data showed that compared with picc, tivap was associated with a higher first-puncture success rate (or:2.028, 95%ci:1.25-3.289, p<0.05), a lower accidental removal rate (or:0.447, 95%ci:0.225-0.889, p<0.05) and lower complication rates, including infection (or:0.570, 95%ci: 0.383-0.850, p<0.05), occlusion (or:0.172, 95%ci:0.092-0.324, p<0.05), malposition (or:0.279, 95%ci:0.128-0.608, p<0.05), thrombosis (or:0.191, 95%ci, 0.111-0.329, p<0.05), phlebitis (or:0.102, 95%ci, 0.038-0.273, p<0.05), allergy (or:0.155, 95%ci:0.035-0.696, p<0.05)."
34343193,PICC infection,"the pooled data showed that compared with picc, tivap was associated with a higher first-puncture success rate (or:2.028, 95%ci:1.25-3.289, p<0.05), a lower accidental removal rate (or:0.447, 95%ci:0.225-0.889, p<0.05) and lower complication rates, including infection (or:0.570, 95%ci: 0.383-0.850, p<0.05), occlusion (or:0.172, 95%ci:0.092-0.324, p<0.05), malposition (or:0.279, 95%ci:0.128-0.608, p<0.05), thrombosis (or:0.191, 95%ci, 0.111-0.329, p<0.05), phlebitis (or:0.102, 95%ci, 0.038-0.273, p<0.05), allergy (or:0.155, 95%ci:0.035-0.696, p<0.05)."
34226216,Cancer,"this pattern continued when only those with malignancy were included in the analysis, those with cancer had twice the risk of thrombosis with a cvr greater than 45%. these results suggest that in individuals with cancer, the use of a cvr ≤45% should be considered to minimise risk of thrombosis."
34226216,PICC insertion procedure,participants: adults who had undergone picc insertion. results: 2438 picc insertions were included with 39 cases of thrombosis (1.6%; 95% ci 1.14% to 2.19%). conclusions: adherence to cvr cut-offs are an important component of picc insertion clinical decision making to reduce the risk of thrombosis.
31556001,PICC infection,"the primary outcome was all complications as well as combined numbers of large vein thrombosis, central-line-associated blood stream infections, and insertional trauma. the combined number of large vein thrombosis, central-line-associated blood stream infection, and insertional trauma was 4/72 in the picc arm and 1/80 in the cvc group (or 4.6 (95% ci 0.5-42.6) p = 0.14)."
34729630,Cancer,"reduction of perioperative venous thrombus formation by antithrombotic peripherally inserted central catheter in esophageal cancer. purpose: although a central venous catheter (cvc) is often needed perioperatively for intraoperative and nutritional management of esophageal cancer (ec), the catheter placement impacts the risk of venous thrombosis."
33244268,Cancer,"the influence of venous characteristics on peripherally inserted central catheter-related symptomatic venous thrombosis in cancer patients. this study aimed to identify effects of venous characteristics on symptomatic picc-related venous thrombosis in cancer patients and explore the relationship between venous characteristics and blood flow velocity. results: a total of 2933 cancer patients were enrolled in this study; of these patients, 68 experienced symptomatic venous thrombosis."
33244268,BMI,"in the bivariate analysis, body mass index (bmi), history of venous thrombosis, triglycerides, tumor category, vessel diameter, vessel depth and arm circumference were associated with thrombosis."
33244268,PICC insertion procedure,"a vein depth of greater than 1.07cm or less than 0.57cm was associated with a higher incidence of picc-related venous thrombosis, and the greater the arm circumference and vessel diameter, the greater the risk of venous thrombosis."
33244268,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"in the bivariate analysis, body mass index (bmi), history of venous thrombosis, triglycerides, tumor category, vessel diameter, vessel depth and arm circumference were associated with thrombosis."
33244268,Slower blood flow velocity,"this study aimed to identify effects of venous characteristics on symptomatic picc-related venous thrombosis in cancer patients and explore the relationship between venous characteristics and blood flow velocity. in october 2017, 169 patients with piccs were enrolled prospectively, and the relationships between blood flow velocity and venous characteristics were recorded and analyzed. blood flow velocity was positively correlated with vessel depth and arm circumference but not with vessel diameter."
33157980,Cancer,"relationship between abo blood group and risk of venous thrombosis in cancer patients with peripherally inserted central catheters: a protocol for systematic review and meta-analysis. in order to provide basis for individual prevention and accurate treatment of vte, the purpose of this study was to explore the relationship between abo blood group and the risk of vte in cancer patients associated with picc through meta-analysis. methods: electronic databases, including embase, cochrane library, pubmed, chinese databases sinomed, chinese national knowledge infrastructure (cnki), chinese scientific journals database (vip), and wanfang data, were searched for case-control studies of abo blood group and picc-related vte in cancer patients. conclusion: this study provided evidence to support the relationship between abo blood group and the risk of picc-related vte in cancer patients."
32880203,Cancer,association between abo blood group and venous thrombosis related to the peripherally inserted central catheters in cancer patients. objective: to evaluate the potential relation between the abo blood group and the risk of venous thrombosis in cancer patients with peripherally inserted central catheters (piccs). methods: the patients who underwent picc catheterization in beijing cancer hospital from january 2018 to october 2019 were retrospectively analyzed.
32880203,Non-O blood type_ group B,"the incidence of symptomatic thrombosis was lower in patients with blood type o when compared with that in patients with blood types other than o. after multivariable adjustment, insertion attempts and the non-o blood type were observed to remain associated with thrombosis. conclusion: the risk of picc-related thrombosis in patients with non-o blood type is significantly higher than that in patients with blood type o."
30560363,ICU,"other risk factors (i.e., age, gender, comorbidity, picc duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with clabsi."
30560363,Gender,"other risk factors (i.e., age, gender, comorbidity, picc duration, veins, hospital stay, and intensive care unit stay) showed no significant correlations with clabsi."
30560363,PICC infection,"objective: to evaluate the impact of subcutaneous tunneling on peripherally inserted central catheter (picc) placement in terms of central line-associated bloodstream infections (clabsis). in each group, procedure times and rates of complications, including clabsi, entry-site infection, dislocation, thrombophlebitis, and occlusion, were examined. key points: • subcutaneous tunnels created to place peripherally inserted central catheters significantly reduced catheter-associated bloodstream infections."
24137199,Cancer,"the complete recanalization of picc-related venous thrombosis in cancer patients: a series of case reports. in this study, cancer patients with venous thrombosis associated with the use of peripherally inserted central catheters (piccs) underwent complete recanalization by the administration of panax notoginseng saponins (pns), which vary from heparin or urokinase in that they do not have the same risks associated with thrombolysis, including bleeding. to the best of our knowledge, this is the first study concerning the treatment of cancers with pns to be reported in the literature. three cancer patients aged 30-50 years old, two females and one male, were subjected to chemotherapy. the results suggest that pns are a feasible and effective treatment option for many types of cancer, but have a broader clinical impact on cancer patients with picc-related venous thrombosis. therefore, this study is an original case report of particular interest to cancer patients with picc-related venous thrombosis."
34096375,PICC insertion procedure,"material and methods: a retrospective study of 2825 adult patients (male 51.2%, female 48.8%) who had a picc insertion from january 2017 to december 2019. result: picc insertion was done in patients with egfr⩽45 ml/min/1.73 m(2) in 26.7% (724/2709) of the sample. the overall death rate for the year post picc insertion was 38.7% (1094/2825), which was significantly higher in low egfr patients (413/724, 57%) compared to patients with egfr>45 ml/min/1.73 m(2) (632/1985, 31.8%) (p-value < 0.0001, odds ratio 2.84 (95% confidence interval 2.38-3.38)). the rate of dialysis initiated in the year post picc insertion was 5.9% (98/1657). conclusion: picc insertion in patients with ckd is practiced frequently."
31764785,Chemotherapy,"peripherally inserted central catheter (picc) is often applied in chemotherapy patients and commonly causes upper extremity venous thrombosis (uevt), which should be prevented.to assess the preventive effects of the anticoagulants rivaroxaban and low molecular weight heparin (lmwh) on uevt in patients receiving chemotherapy through piccs.a total of 423 chemotherapy patients with continuous picc use between january 2014 and june 2015 at the oncology department of dongying people's hospital were divided into 3 groups: rivaroxaban (10 mg/day, orally), lmwh (enoxaparine, 4000 anti-xa iu/day, subcutaneous injection), and control (no anticoagulant). there were significant differences in the rivaroxaban group and the lmwh group compared to the control group (p = .010 and p = .009, respectively), but no significant difference was observed between the rivaroxaban group and the lmwh group (p = .743).anticoagulants such as rivaroxaban and lmwh may reduce the incidence of picc-related uevt in patients receiving chemotherapy."
31764785,Cancer,"the anticoagulants rivaroxaban and low molecular weight heparin prevent picc-related upper extremity venous thrombosis in cancer patients. there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)."
31764785,Gender,"uevt incidence and other complications during picc use were observed and recorded.the rivaroxaban, lmwh, and control groups included 138 (79 males; 54.9 ± 11.0 years), 144 (76 males; 56.0 ± 10.9 years), and 141 (71 males; 53.3 ± 10.9 years) patients, (p = .402 and p = .623 for age and sex respectively)."
31764785,BMI,"there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)."
31764785,Smoking,"there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)."
31764785,Age,"uevt incidence and other complications during picc use were observed and recorded.the rivaroxaban, lmwh, and control groups included 138 (79 males; 54.9 ± 11.0 years), 144 (76 males; 56.0 ± 10.9 years), and 141 (71 males; 53.3 ± 10.9 years) patients, (p = .402 and p = .623 for age and sex respectively)."
31764785,Number of comorbidities/HTA/Hyperglycemia,"there were no differences in cancer location (p = .628), picc implantation site (p > .05), body mass index (bmi) (p = .434), blood pressure (all p > .05), blood lipids (5 laboratory parameters included, all p > .5), smoking (p = .138), history of lower limb venous thrombosis (p = .082), and 10 other associated comorbidities (all p > .5)."
31764785,Anticoagulants therapy,"the anticoagulants rivaroxaban and low molecular weight heparin prevent picc-related upper extremity venous thrombosis in cancer patients. peripherally inserted central catheter (picc) is often applied in chemotherapy patients and commonly causes upper extremity venous thrombosis (uevt), which should be prevented.to assess the preventive effects of the anticoagulants rivaroxaban and low molecular weight heparin (lmwh) on uevt in patients receiving chemotherapy through piccs.a total of 423 chemotherapy patients with continuous picc use between january 2014 and june 2015 at the oncology department of dongying people's hospital were divided into 3 groups: rivaroxaban (10 mg/day, orally), lmwh (enoxaparine, 4000 anti-xa iu/day, subcutaneous injection), and control (no anticoagulant). there were significant differences in the rivaroxaban group and the lmwh group compared to the control group (p = .010 and p = .009, respectively), but no significant difference was observed between the rivaroxaban group and the lmwh group (p = .743).anticoagulants such as rivaroxaban and lmwh may reduce the incidence of picc-related uevt in patients receiving chemotherapy."
35287828,Cancer,"the role of body mass index in the development of thromboembolic events among cancer patients with piccs: a systematic review. the aim of this systematic review is to analyze the available scientific literature in order to determine whether bmi could represent a risk factor in the development of thromboembolic event among cancer patients with piccs. the primary endpoint was the relative risk (rr) of picc-related thrombosis of overweight/obese vs normal weight/underweight (i.e., bmi ≥25 vs <25 kg/m(2)) in cancer patients. underweight condition could also play a role in thrombosis development, especially in nasopharyngeal and digestive system cancer."
35287828,BMI,"the role of body mass index in the development of thromboembolic events among cancer patients with piccs: a systematic review. among the identification of independent risk factors, the role of body mass index (bmi) ≥25 kg/m(2) is now emerging in literature with conflicting results. the aim of this systematic review is to analyze the available scientific literature in order to determine whether bmi could represent a risk factor in the development of thromboembolic event among cancer patients with piccs. these criteria included the english language, oncological patients with piccs, the evaluation of catheter-related thrombosis as well as the stratification of patients according to bmi. the primary endpoint was the relative risk (rr) of picc-related thrombosis of overweight/obese vs normal weight/underweight (i.e., bmi ≥25 vs <25 kg/m(2)) in cancer patients. concerning bmi, 52.6% of the entire population was overweight/obese."
35287828,Age,conclusion: this review showed a two-fold risk of thrombosis in overweight/obese compared to normal weight/underweight oncological patients with piccs.
28218366,Cancer,"peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days. purpose: to evaluate incidence and risk factors of peripherally inserted central catheter (picc)-related complications in cancer patients. methods: a prospective, multicenter, cohort study of cancer patients with picc insertion was performed from february 1, 2013 to april 24, 2014. results: there were 477 cancer patients included, for a total of 50,841 catheter-days. conclusions: cancer patients with bmi greater than 25 were more likely to have picc complications."
28218366,BMI,"in multivariable analysis, body mass index (bmi) >25 (odds ratio, 2.09; 95% confidence interval, 1.26-3.47, p = 0.004) was shown to be a significant risk factor for picc complications. conclusions: cancer patients with bmi greater than 25 were more likely to have picc complications."
28218366,PICC indwelling time,"peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days. eighty-one patients (17.0%) developed picc-related complications, with an incidence of 1.59 per 1000 catheter days. nine (1.9%) patients developed symptomatic upper extremity deep venous thrombosis (uedvt) and central line associated bloodstream infection (clabsi) was shown in six (1.3%) piccs with an infection rate 0.12 per 1000 catheter days."
28218366,PICC infection,nine (1.9%) patients developed symptomatic upper extremity deep venous thrombosis (uedvt) and central line associated bloodstream infection (clabsi) was shown in six (1.3%) piccs with an infection rate 0.12 per 1000 catheter days.
35645580,Diabete,"in univariate and multivariate analyses, diabetes mellitus was associated with catheter-related infection. in univariate and multivariate analyses, diabetes mellitus and fluoroscopy-guided insertion were associated with favorable catheter survival."
35645580,PICC insertion procedure,conclusion: the results of our study showed high success and low complication rates for picc insertion by nephrologists.
35645580,PICC infection,"the reasons for catheter removal were classified as accidental removal; treatment termination; catheter occlusion; vessel thrombosis; catheter-related infection, or patient death. overall catheter complications were defined as catheter occlusion, vessel thrombosis, or catheter-related infection. in univariate and multivariate analyses, diabetes mellitus was associated with catheter-related infection."
28978332,PICC infection,"the primary outcome was picc failure, a composite of picc removal for local infection, catheter-associated bloodstream infection, dislodgement, occlusion, and/or catheter fracture."
26312402,PICC infection,"major (central line-associated bloodstream infection, venous thromboembolism, catheter dislodgement) and minor (migration, dressing disruption, lumen occlusion, exit site infection) complications and process measures (flushing of picc, assessment of necessity) were recorded."
28936124,Chemotherapy,"statistically significant risk factors for developing prdvt in multivariate analysis included more than one attempt for insertion (or 2.61, 95%ci: 1.12-6.05) and the use of fluoropyrimidine containing chemotherapy (or 4.27, 95%ci 1.3-14.07). when all-type vte were considered together fluoropyrimidine containing chemotherapy (or 4.54, 95% ci 1.63-12.61), male gender (or 2.03, 95% ci 1.04-3.93) and white cell count (or 1.12, 95% ci 1.00-1.26) were statistically significant as risk factors in this analysis. fluoropyrimidine containing chemotherapy and more than one attempt for picc insertion were independent predictors of picc-associated vte whilst the former remained an independent predictor of all-type vte."
28936124,Cancer,"the risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients. piccs are increasingly utilised in the management of cancer patients, a group which carries both additional risks for vascular thromboembolism as well as for complex morbidity. we analysed a cohort of cancer patients subjected to picc insertion in a single cancer centre for the incidence of all-type vascular thromboembolism (vte) and investigated relative risk factors. conclusions: this is a large study of vte following picc insertion in cancer patients which also looks at the rate of distant vte."
28936124,Gender,"male gender was the only significant risk factor for distant vte. when all-type vte were considered together fluoropyrimidine containing chemotherapy (or 4.54, 95% ci 1.63-12.61), male gender (or 2.03, 95% ci 1.04-3.93) and white cell count (or 1.12, 95% ci 1.00-1.26) were statistically significant as risk factors in this analysis."
28936124,PICC insertion procedure,"we analysed a cohort of cancer patients subjected to picc insertion in a single cancer centre for the incidence of all-type vascular thromboembolism (vte) and investigated relative risk factors. methods: in this clinical audit, the records of patients referred for picc insertion in our centre in the period between 1/1/2011 and 1/4/2014 were retrospectively reviewed. the kaplan meier method was used to study time from picc insertion to prdvt/vte. conclusions: this is a large study of vte following picc insertion in cancer patients which also looks at the rate of distant vte. fluoropyrimidine containing chemotherapy and more than one attempt for picc insertion were independent predictors of picc-associated vte whilst the former remained an independent predictor of all-type vte."
30594171,Cancer,"symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis. background: despite increasing use, symptomatic venous thromboembolism (vte) associated with peripherally inserted central catheter (picc) is a common complication in nonmetastatic nasopharyngeal carcinoma (npc) patients."
30594171,Anticoagulants therapy,"subgroup analyses indicated that no significant survival difference was found between picc-related superficial venous thrombosis and deep vein thrombosis, nor did different anticoagulant treatment methods."
31721153,Cancer,cost analysis comparison between peripherally inserted central catheters and implanted chest ports in patients with cancer-a health economic evaluation of the piccport trial. background: a reliable central venous access device is a cornerstone in the treatment of cancer. method: we conducted a randomized controlled trial including 399 patients with cancer and performed a health economic evaluation investigating the cost related to piccs and ports using several clinically relevant dimensions from a healthcare perspective. conclusion: we have demonstrated that the cost from a healthcare perspective is higher in cancer patients receiving a picc than to those with a port.
37046808,Chemotherapy,"intravascular complications of central venous catheterization by insertion site in acute leukemia during remission induction chemotherapy phase: lower risk with peripherally inserted catheters in a single-center retrospective study. in a 10-year period, 336 cvc were inserted in the bbv (n = 115), ijv (n = 111), and scv (n = 110) in 336 patients suffering from aml (n = 201) and all (n = 135) and undergoing induction chemotherapy. picc was a valid cvc for the induction chemotherapy of acute leukemia for the lowest risk of sdvt and bsi."
37046808,Cancer,"intravascular complications of central venous catheterization by insertion site in acute leukemia during remission induction chemotherapy phase: lower risk with peripherally inserted catheters in a single-center retrospective study. a bbv approach [peripherally inserted central catheter (picc)] is increasingly used for short- to intermediate-term cvcs for acute leukemias undergoing cytotoxic intensive regimens. in this retrospective study, the catheterization of the bbv, ijv, and scv in patients with previously untreated acute leukemia was assessed. picc was a valid cvc for the induction chemotherapy of acute leukemia for the lowest risk of sdvt and bsi."
31445252,Cancer,"machine learning approaches for risk assessment of peripherally inserted central catheter-related vein thrombosis in hospitalized patients with cancer. design: we conducted a prospective cohort study of 348 cancer patients with piccs who were admitted to the department of oncology of west china hospital, over a 1-year period, between february 1, 2016, and february 31, 2017. conclusions: our research confirmed that ml approaches are powerful tools to identify cancer patients with a high risk of picc-related thrombosis, which outperform the currently used criteria (seeley). from our research, more-precise assessments can be performed in cancer patients with piccs to help decide the prophylaxis and effectively lower the incidence of picc-related thrombosis."
24781722,Chemotherapy,"thrombotic risk factors in patients undergoing chemotherapy via peripherally inserted central catheter. objective: to evaluate risk factors for venous thrombosis in patients undergoing chemotherapy via peripherally inserted central catheter (picc). conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy."
24781722,BMI,"methods: data regarding age, sex, body mass index (bmi), smoking history, diagnosis, medical history, family history of thrombosis, haemoglobin level, and white blood cell (wbc) and platelet counts were prospectively collected from consecutively recruited patients. age >60 years, bmi >25 kg/m(2) and wbc >11.4 × 10(9)/l were identified as independent risk factors for thrombosis. conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy."
24781722,Age,"conclusions: age >60 years, bmi >25 kg/m(2) and wbc >1.4 × 10(9)/l are major risk factors for thrombosis in chinese patients undergoing picc chemotherapy."
30384035,ICU,"we report the rate of vte in intensive care unit (icu) medical patients receiving picc, cvc, both, or neither."
26113804,PICC infection,"post-thrombotic complication rates, particularly infection, were higher in the picc group compared to the ltstc group (p = 0.597)."
28740162,PICC insertion procedure,we retrospectively reviewed a database of 320 consecutive patients who underwent picc insertion between december 2014 and december 2015 at the first affiliated hospital of xi'an jiaotong university to explore the potential associations between risk factors and picc-associated thrombosis.
24911379,BMI,"in multivariable logistic regression analyses, malnutrition and after-hours placement were significantly associated with increased risk of complications, as was body mass index (bmi) >30 after adjusting for anticoagulation and time of placement. conclusions: screening of patients undergoing picc placement with attention to malnutrition, bmi >30, and length of stay may reduce the risk of picc-associated complications."
24911379,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"in our multivariable logistic regression analyses, use of anticoagulation/antiplatelet agents was associated with decreased risk of all-cause complications, nonmechanical complications, and catheter-associated thrombosis. use of anticoagulation/antiplatelet agents and avoiding after-hours placement may reduce complications and enhance patient safety."
24911379,PICC infection,"complications included catheter-associated thrombosis (3%), mechanical complications (4%), catheter-associated bloodstream infections (2%), and cellulitis (1%)."
31981040,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),management of anticoagulant therapy according to the platelet count. uedvt treatment was compared in 3 groups: patients with a platelet count ≥ 50 × 10(9)/l (group1) who underwent a therapeutic dose of low molecular weight heparin (lmwh) or fondaparinux 7.5 mg; patients with a platelet count < 50 × 10(9)/l and ≥ 30 × 10(9)/l (group 2) who were treated with a 50% reduced dose of lmwh or fondaparinux 5 mg; patients with platelets < 30 × 10(9)/l (group 3) were observed and treated with anticoagulants when the count was > 30 × 10(9)//l.
31981040,Anticoagulants therapy,management of anticoagulant therapy according to the platelet count. uedvt treatment was compared in 3 groups: patients with a platelet count ≥ 50 × 10(9)/l (group1) who underwent a therapeutic dose of low molecular weight heparin (lmwh) or fondaparinux 7.5 mg; patients with a platelet count < 50 × 10(9)/l and ≥ 30 × 10(9)/l (group 2) who were treated with a 50% reduced dose of lmwh or fondaparinux 5 mg; patients with platelets < 30 × 10(9)/l (group 3) were observed and treated with anticoagulants when the count was > 30 × 10(9)//l. we observed no hemorrhagic or thrombotic complications related to the anticoagulant therapy; length of treatment was comparable between groups 1 and 2 (51 days group 1 vs 50 days group 2).
35279504,Cancer,"risk of vte associated with ports and piccs in cancer patients: a systematic review and meta-analysis. objective: we aimed to study the incidence of port-related vte and picc-related vte in cancer patients by a meta-analysis. cohort studies and randomized controlled trials (rcts) comparing port-related vte and picc-related vte in cancer patients were included. our meta-analysis of 22 studies suggested that the risk of port-related vte was lower than that of picc-related vte in cancer patients (or = 0.38, 95% ci: 0.25-0.58). conclusions: ports are associated with a lower risk of vte than piccs in cancer patients. the risk of vte and benefits should be considered when selecting ports or piccs for cancer patients."
34095299,Diabete,"the relevant data for the participants, including general information (gender, age, smoking, and drinking), comorbidities (diabetes, hypertension, and anemia), tumor-related data (tumor site, histology, degree of differentiation, and clinical stage), and treatment-related data (surgery, chemotherapy, hormones, transfusion, and peripherally inserted central venous catheter (picc)), were collected. the results demonstrate a statistically significant difference in age, diabetes, hypertension, histology, surgery, chemotherapy, and picc (p < 0.05), compared with control. age, diabetes, surgery, and picc serve as independent risk factors for gc-associated thrombotic diseases (p < 0.05). the present work demonstrates that gc-associated thrombotic diseases are significantly associated with age, diabetes, surgery, and picc, suggesting a potential target for early detection and preventive strategy for gc patients with thrombophilia."
34095299,Cancer,risk factors for gastric cancer-associated thrombotic diseases in a han chinese population. the aim of the present work was to investigate the risk factors for gastric cancer- (gc-) associated thrombotic diseases in a han chinese population.
34095299,Surgery_type of surgery,"the relevant data for the participants, including general information (gender, age, smoking, and drinking), comorbidities (diabetes, hypertension, and anemia), tumor-related data (tumor site, histology, degree of differentiation, and clinical stage), and treatment-related data (surgery, chemotherapy, hormones, transfusion, and peripherally inserted central venous catheter (picc)), were collected. the results demonstrate a statistically significant difference in age, diabetes, hypertension, histology, surgery, chemotherapy, and picc (p < 0.05), compared with control. age, diabetes, surgery, and picc serve as independent risk factors for gc-associated thrombotic diseases (p < 0.05). the present work demonstrates that gc-associated thrombotic diseases are significantly associated with age, diabetes, surgery, and picc, suggesting a potential target for early detection and preventive strategy for gc patients with thrombophilia."
34095299,Thrombophilia,"the present work demonstrates that gc-associated thrombotic diseases are significantly associated with age, diabetes, surgery, and picc, suggesting a potential target for early detection and preventive strategy for gc patients with thrombophilia."
25680892,Chemotherapy,"multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis."
25680892,Diabete,"multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis."
25680892,BMI,"multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis."
25680892,History Of Thrombosis,"multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis."
25680892,Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h,"identification of patient-related risk factors could lead to early recognition of upper limb deep vein thrombosis in patients with catheters, thereby preventing complications."
25680892,Thrombophilia,"multiple studies identified age, malignancy, diabetes, obesity, chemotherapy, thrombophilia and a history of thrombosis as significant risk factors for catheter-related thrombosis."
34454607,PICC insertion procedure,"the success rate of the first catheterization, the success rate of the catheterization, the timing of the catheterization, the complications and the position of the catheter end were compared between the two groups."
37736715,Chemotherapy,"clinical characteristics of peripherally inserted central catheter-related complications in cancer patients undergoing chemotherapy: a prospective and observational study. the purpose of this study was to investigate the clinical characteristics of picc-related complications in cancer patients undergoing chemotherapy. conclusions: picc-related complications were pretty common in cancer patients undergoing chemotherapy. because more than half of the patients with picc-related complications could be managed with conventional interventions, piccs remain a priority for cancer patients undergoing short-term chemotherapy."
37736715,Cancer,"clinical characteristics of peripherally inserted central catheter-related complications in cancer patients undergoing chemotherapy: a prospective and observational study. purpose: the incidence of peripherally inserted central catheter (picc)-related complications is higher in cancer patients than in noncancer patients. the purpose of this study was to investigate the clinical characteristics of picc-related complications in cancer patients undergoing chemotherapy. cancer patients undergoing picc insertion for anticancer treatment were recruited and followed up until the first week after catheter removal. conclusions: picc-related complications were pretty common in cancer patients undergoing chemotherapy. because more than half of the patients with picc-related complications could be managed with conventional interventions, piccs remain a priority for cancer patients undergoing short-term chemotherapy."
37736715,PICC insertion procedure,cancer patients undergoing picc insertion for anticancer treatment were recruited and followed up until the first week after catheter removal.
37736715,PICC infection,"catheter fracture and catheter-related bloodstream infection were classified as the ""late onset"" group occurring after the second month post-insertion. marsi, catheter dislodgement, occlusion, and insertion site infection were classified as the ""persistent onset"" group persistently occurring during the whole catheter-dwelling period."
27240799,PICC infection,background: central line-associated bloodstream infections (clabsis) are a common life-threatening risk factor associated with central venous catheters (cvcs).
25616129,PICC infection,"during follow up of piccs, catheter infection rate was 0.3/1000 days, vein thrombosis rate 0.4/1000 days, catheter occlusion 0.4/1000 days, and catheter displacement 0.33/1000 days. for midline catheters infection rate was 1.4/1000 days, vein thrombosis 5.2/1000 days, catheter occlusion 2.6/1000 days, and catheter displacement 2.2/1000 days."
25634150,PICC infection,"joanna briggs institute tools were used to extract data from the final 19 articles with information collated relating to catheter type, patient type, overall complication rate, rates of infection, occlusion, dislodgment, phlebitis, thrombus and rupture. although both lines saw similar overall rates upon closer observation, the strengths and weaknesses of both lines are shown.polyurethane picc lines were found to provide lower rates of infection, dislodgment, thrombus and rupture complications.mixed results were found with catheter line occlusions, overall averages showing polyurethane lines slightly higher rates than silicone."
31005243,Chemotherapy,"background: centrally inserted totally implanted vascular access ports (ports) and peripherally inserted central catheters (piccs) are widely used for the administration of chemotherapy. our aim was to study the incidence of catheter-related deep venous thrombosis in patients with cancer receiving chemotherapy through either a picc or a port. this increased risk should be considered when choosing a vascular access device for chemotherapy, especially in patients with solid malignancy."
31005243,Cancer,"clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial. our aim was to study the incidence of catheter-related deep venous thrombosis in patients with cancer receiving chemotherapy through either a picc or a port. methods: adults with non-haematological cancer (mainly breast and colorectal) from two swedish oncology centres were included and followed for up to 1 yr."
38105233,Chemotherapy,"logistic regression analysis showed that age (p = 0.0444), temperature (p = 0.0317), amount of blood loss (p = 0.0067), picc (p < 0.0001), chemotherapy (p = 0.0459), anemia (p = 0.0007), international normalized ratio (p = 0.003) and ca199 (p = 0.0234) were independent risk factors for vte."
38105233,Cancer,"risk factors of venous thromboembolism in inpatients with colorectal cancer in china. to explore the risk factors for venous thromboembolism (vte) in inpatients with colorectal cancer. the demographic factors, comorbidities, and hematological indices of patients with colorectal cancer treated in our hospital from 2016 to 2021 were collected and recorded. clinical parameters are associated with vte in inpatients with colorectal cancer, which will help to guide clinicians to take effective measures to improve the patients' prognosis."
38105233,Smoking,"comparing the clinical data of 293 cases of non-vte group and 235 cases of vte group, we found significant differences in age, smoking, temperature, amount of blood loss, differentiation degree, peripherally inserted central catheter (picc), radiotherapy, anemia, infection, white blood cell count, prothrombin time (pt), pt%, prothrombin ratio, international normalized ratio, thrombin time, ca199 and cea between the two groups (p < 0.05)."
38105233,Age,"logistic regression analysis showed that age (p = 0.0444), temperature (p = 0.0317), amount of blood loss (p = 0.0067), picc (p < 0.0001), chemotherapy (p = 0.0459), anemia (p = 0.0007), international normalized ratio (p = 0.003) and ca199 (p = 0.0234) were independent risk factors for vte."
38105233,Number of comorbidities/HTA/Hyperglycemia,"the demographic factors, comorbidities, and hematological indices of patients with colorectal cancer treated in our hospital from 2016 to 2021 were collected and recorded."
38105233,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"comparing the clinical data of 293 cases of non-vte group and 235 cases of vte group, we found significant differences in age, smoking, temperature, amount of blood loss, differentiation degree, peripherally inserted central catheter (picc), radiotherapy, anemia, infection, white blood cell count, prothrombin time (pt), pt%, prothrombin ratio, international normalized ratio, thrombin time, ca199 and cea between the two groups (p < 0.05)."
38105233,PICC infection,"comparing the clinical data of 293 cases of non-vte group and 235 cases of vte group, we found significant differences in age, smoking, temperature, amount of blood loss, differentiation degree, peripherally inserted central catheter (picc), radiotherapy, anemia, infection, white blood cell count, prothrombin time (pt), pt%, prothrombin ratio, international normalized ratio, thrombin time, ca199 and cea between the two groups (p < 0.05)."
36013377,Chemotherapy,central venous access and the risk for thromboembolic events in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer. thromboembolic events (tee) are high-risk complications in patients undergoing neoadjuvant chemotherapy (nac) and radical cystectomy (rc) for urothelial muscle-invasive bladder cancer (mibc).
36013377,Cancer,central venous access and the risk for thromboembolic events in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer. thromboembolic events (tee) are high-risk complications in patients undergoing neoadjuvant chemotherapy (nac) and radical cystectomy (rc) for urothelial muscle-invasive bladder cancer (mibc).
28619777,Cancer,"peripherally inserted central catheter dressing and securement in patients with cancer: the pisces trial. patients with cancer are at highest risk, and this increases morbidity, mortality and costs."
28619777,PICC infection,"for the dressing hypothesis, we hypothesise chg discs will reduce catheter-associated bloodstream infection (cabsi) compared with no chg disc. for the securement hypothesis, we hypothesise that isd will reduce composite picc failure (infection (cabsi/local infection), occlusion, dislodgement or thrombosis), compared with sed."
37883756,Cancer,"a novel model to prevent venous thromboembolism in patients with lung cancer. objective: to observe the effect of nurse-patient co-management mode on preventing venous thromboembolism (vte) in lung cancer patients with carboplatin and gemcitabine chemotherapy after peripheral venipuncture central venous catheterization (picc). methods: 100 patients with lung cancer admitted to the 2nd affiliated hospital of hainan medical university from april 2020 to april 2022 were selected. patients in the control group were given routine nursing for lung cancer, and patients in the observation group were treated with nurse-patient co-management mode, and nursing intervention lasted for 2 months."
35086961,PICC infection,"picc-related major (deep vein thrombosis (dvt), central line-associated bloodstream infection (clabsi) and catheter occlusion) and minor complications were collected."
33908337,ICU,"multivariable cox proportional hazards models with robust sandwich standard error estimates accounting for the clustered nature of data were used to identify factors associated with picc complications in coated versus noncoated devices across general care, intensive care unit (icu), and oncology patients."
33908337,PICC infection,"objective: to examine the effectiveness of antimicrobial and antithrombogenic materials incorporated into peripherally inserted central catheters (piccs) to prevent bloodstream infection, thrombosis, and catheter occlusion. within the entire cohort, 540 (1.3%) developed thrombosis, 745 (1.8%) developed bloodstream infection, and 4,090 (9.6%) developed catheter occlusion. adjusting for known risk factors, antimicrobial piccs were not associated with infection reduction (hr, 1.16; 95% ci, 0.82-1.64), and antithrombogenic piccs were not associated with reduction in thrombosis and occlusion (hr, 1.15; 95% ci, 0.92-1.44)."
37572590,Cancer,"the clinical topography of peripherally inserted central catheter-related thrombosis in cancer patients: a prospective and longitudinal observational study based on ultrasound scans every two days. aims: to delineate the clinical topography of peripherally inserted central catheter (picc)-related thrombosis in cancer patients. methods: cancer patients scheduled for picc placement were potentially eligible; patients with contraindications to picc placement or existing diseases affecting blood flow were excluded; and those who later withdrew or did not reply to our contact request during the follow-up period were eliminated from this study. conclusion: picc-related thrombosis is common and can occur very early post insertion in cancer patients, and most thromboses present atypical symptoms."
25198809,Chemotherapy,"aim: the aim of this study is to compare the complication rates of three vascular access devices in patients with solid tumours having infusion chemotherapy. materials and methods: an observational study of 58 central venous catheter (cvc) lines inserted in 55 patients with solid tumours requiring infusional chemotherapy was performed. results: the two cvc groups (ports and non-ports) matched equally in terms of tumour site; all patients with solid tumours were included, haematology patients were excluded and chemotherapy regimens were comparable. conclusions: in our study, we demonstrated that central venous ports and picc lines in patients undergoing infusional chemotherapy had lower line infection rates than tunnelled catheters, and only ports have been shown to be almost complication-free. therefore, we recommend that central venous ports are a safe, acceptable cvc option for infusional chemotherapy for adults with solid tumours."
25198809,PICC infection,"a comparison of infections and complications in central venous catheters in adults with solid tumours. the study was conducted between january 2011 and august 2013, looking at complication and infection rates as primary outcomes. ten out of 19 tunnelled catheters had complications including three displacements and seven were removed due to infection. conclusions: in our study, we demonstrated that central venous ports and picc lines in patients undergoing infusional chemotherapy had lower line infection rates than tunnelled catheters, and only ports have been shown to be almost complication-free. in addition, we found infection rates higher in cvcs s cared for by patient/carers rather than hospital only care, and higher in colorectal patients with stomas."
25953205,Age,"after multivariate analysis, two risk factors were significantly associated with the overall occurrence of complications: age more than 70 years [or = 2.89 (1.06-7.89], p = 0.04] and number of lumen at least two [or = 2.64 (1.03-6.75), p = 0.04]."
25953205,PICC insertion procedure,"all picc complications were recorded during the patient hospitalization: infection [catheter-related bloodstream infection (crbsi), central line associated bloodstream infection (clabsi), exit-site infection, septic phlebitis], thrombosis, occlusion, mechanical complication (accidental withdrawal, malposition, median nerve irritation). aeruginosa), two exit-site infections and 10 clabsis), 11 (6%) occlusions, and 12 (7%) mechanical complications (10 accidental withdrawals, one malposition, one median nerve irritation)."
25953205,PICC infection,"evaluation of picc complications in orthopedic inpatients with bone infection for long-term intravenous antibiotics therapy. purpose: the purpose of this study is to evaluate the complications of peripherally inserted central catheters (piccs) in orthopedic patients with chronic bone orthopedic infection. all patients had bones infections necessitating a long-term intravenous antibiotics therapy. all picc complications were recorded during the patient hospitalization: infection [catheter-related bloodstream infection (crbsi), central line associated bloodstream infection (clabsi), exit-site infection, septic phlebitis], thrombosis, occlusion, mechanical complication (accidental withdrawal, malposition, median nerve irritation). thirty-six piccs (20%) were removed due to complications (9.2 complications per 1000 picc-days): 14 (8%) infections (one crbsi (pseudomonas aeruginosa), one septic phlebitis (p. aeruginosa), two exit-site infections and 10 clabsis), 11 (6%) occlusions, and 12 (7%) mechanical complications (10 accidental withdrawals, one malposition, one median nerve irritation). conclusions: even in orthopedic patients with chronic orthopedic bone infection, piccs have a low rate of complication."
34973357,Two or more lumens,"in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care. the number of catheter lumens is one of the modifiable factors to reduce complications."
34973357,Diabete,"in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care. conclusions: in our study, the use of kt fix plus did not reduce the risk of complications adjusting for other risk factors such as obesity and diabetes."
34973357,BMI,"in multivariate cox analysis, independent risk factors for picc-associated complications were obesity (adjusted hazard ratio (ahr), 1.08, p < .001) and diabetes (ahr, 1.85, p = .039), adjusting for chronic renal failure, number of lumens, catheter/vein diameter ratio and duration of home-based care. conclusions: in our study, the use of kt fix plus did not reduce the risk of complications adjusting for other risk factors such as obesity and diabetes."
34973357,PICC infection,"the primary endpoint was the composite of picc-associated complications until removal, including occlusion, migration, accidental withdrawal, infection, thrombosis, and hematoma."
31073442,Surgery_type of surgery,"purpose  right atrial (ra) or intracardiac lines are commonly used for hemodynamic monitoring in children undergoing cardiac surgery. methods  after approval from the institutional review board, a retrospective review of all patients undergoing cardiac surgery at arkansas children's hospital between the dates of january 1, 2006 and december 31, 2011 was performed. disease severity as assessed by risk-adjusted classification for congenital heart surgery (rachs) score ( p  < 0.046), year of placement ( p  < 0.001), and line type adjusted for thrombolytic (alteplase) use are significantly associated with risk of any cabsi."
31073442,PICC infection,"catheter-associated blood stream infections in intracardiac lines. in some institutions, these lines are used as the preferred long-term access line due to concerns for catheter-associated blood stream infections (cabsi) and catheter-related venous thrombosis with central lines in other locations."
34297997,PICC infection,"the primary outcome was complication rate (composite of infection, venous thrombosis, pulmonary embolus, inability to aspirate blood, mechanical failure, and other) assessed until device removal, withdrawal from study, or 1-year follow-up."
36960818,Two or more lumens,"nudging to select single-lumen over multiple-lumen peripherally inserted central catheters (piccs) in a large safety net system. compared to multilumen piccs, single-lumen piccs carry a lower rate of complications, including central-line-associated bloodstream infection and thrombosis. despite this, multilumen piccs are still overused."
36960818,PICC infection,"compared to multilumen piccs, single-lumen piccs carry a lower rate of complications, including central-line-associated bloodstream infection and thrombosis. clabsi rates had a nonsignificant reduction by 26.7% from 2.44 to 1.79 infections per month (p = .255)."
34711086,Cancer,"methods: in this randomized controlled trial, 120 cancer patients were randomly assigned to the upper portion of the red zone (rz), the green zone (gz) and the lower portion of the yellow zone (yz) groups (at a 1:1:1 ratio). the aim was to compare the degree of patient comfort and the incidence of major picc complications among the three insertion zones based on the zim(tm) in a chinese cancer center."
34711086,PICC insertion procedure,"conclusions: this study found that the lower portion of yz seems to be another suitable picc insertion site for a higher degree of comfort and a lower risk of occlusion and thrombosis, which broadens the choice of picc insertion sites in the upper arm for clinical practice."
26519981,ICU,complication rates among peripherally inserted central venous catheters and centrally inserted central catheters in the medical intensive care unit. purpose: there are limited contemporary data describing the rates of catheter-related deep vein thrombosis (crdvt) and central line-associated bloodstream infection for peripherally inserted central venous catheters (piccs) and centrally inserted central venous catheters (ciccs) in the medical intensive care unit (icu).
26519981,PICC infection,"purpose: there are limited contemporary data describing the rates of catheter-related deep vein thrombosis (crdvt) and central line-associated bloodstream infection for peripherally inserted central venous catheters (piccs) and centrally inserted central venous catheters (ciccs) in the medical intensive care unit (icu). central line-associated bloodstream infection was defined according to federal reporting criteria. only 1 central line-associated bloodstream infection occurred in a picc following icu dismissal, p > .999."
26217634,PICC infection,"the most common catheter-related complication was thrombosis (12, 8.8%) followed by infection (8, 5.8%)."
36644041,Surgery_type of surgery,"this study aims to identify the incidence of deep vein thrombosis (dvt) and superficial vein thrombosis (svt) among post-craniotomy/craniectomy patients and further evaluate established hypercoagulability risk factors such as trauma, tumors, and surgery. this model included variables such as age, post-operative days before anticoagulant administration, female sex, indications for surgery such as tumor and trauma, presence of a picc line, and anticoagulant administration. the multivariate logistic regression analysis found that increasing the number of days between surgery and administration of anticoagulants significantly increased the risk of vte incidence (odds ratio 1.183, 95% ci 1.068-1.311, p = 0.001)."
36644041,Anticoagulants therapy,"this model included variables such as age, post-operative days before anticoagulant administration, female sex, indications for surgery such as tumor and trauma, presence of a picc line, and anticoagulant administration. the multivariate logistic regression analysis found that increasing the number of days between surgery and administration of anticoagulants significantly increased the risk of vte incidence (odds ratio 1.183, 95% ci 1.068-1.311, p = 0.001). future prospective studies should assess vte risk assessment models such as ""3 bucket"" or ""caprini"" to develop universal guidelines for administering anticoagulant therapy to post-craniotomy/craniectomy patients that consider the timing of post-operative therapy initiation."
35495896,Slower blood flow velocity,"secondly, we compared the average blood flow velocity per unit time of axillary vein at different moments. the average blood flow velocity per unit time of axillary vein in the study group was faster compared to the control at different time points (p < 0.05). in terms of the average blood flow velocity per unit time of axillary vein at different time points between the two groups, there exited no significant difference before catheterization (p > 0.05). but 14 and 28 days after catheterization, the average blood flow velocity per unit time of axillary vein in the study group was better when compared to the control (p < 0.05). there was no significant difference in vascular diameter, peak blood flow velocity, and vascular pressure between the two groups before nursing (p > 0.05), but after nursing, the vascular diameter and peak blood flow velocity group were higher, and the vascular pressure was lower in the study (p < 0.05)."
33594508,Cancer,"assessing the thrombosis risk of peripherally inserted central catheters in cancer patients using caprini risk assessment model: a prospective cohort study. purpose: there was no optimal risk assessment tool to stratify the risk of peripherally inserted central catheter-related venous thromboembolism (picc-rvt) in cancer patients. this study was to assess the validity of the caprini in chinese cancer patients with piccs. conclusions: the caprini can be used for high-risk screening of the picc-rvt in cancer patients, and classification of the highest risk level using a score of 6 can be more clinically significant compared to 5 as recommended."
25377903,PICC indwelling time,"results: of the 163 patients who represented 19104 home-catheter days, 19 (11.7%) patients experienced 25 catheter complications (ccs; 12 occlusions, 11 central line-associated bloodstream infections, one thrombosis and one line dislodgment)."
25377903,PICC infection,"results: of the 163 patients who represented 19104 home-catheter days, 19 (11.7%) patients experienced 25 catheter complications (ccs; 12 occlusions, 11 central line-associated bloodstream infections, one thrombosis and one line dislodgment)."
24983259,BMI,"hypertension (p = .022) and obesity (p = .008), defined as a body mass index ≥30, were associated with uedvt."
24983259,Hypertension,"hypertension (p = .022) and obesity (p = .008), defined as a body mass index ≥30, were associated with uedvt."
33019880,Chemotherapy,"safe use of peripherally inserted central catheters for chemotherapy of solid malignancies in adult patients: a 1-year monocentric, prospectively-assessed, unselected cohort of 482 patients. introduction: aim of this study was to analyze the overall complication and failure rates of peripherally inserted central catheters (piccs), in a 1-year consecutive unselected cohort of 482 adult patients, affected by non-hematological malignancies undergoing chemotherapy. methods: adult outpatients (aged 18-75 years), with an eastern cooperative oncology group (ecog) performance status of 0-2, bearing solid tumors and candidates for intravenous chemotherapy were eligible for the study. conclusion: this large prospective study supports the increasing use of piccs in adult oncology outpatients treated in specialized centers with chemotherapy for non-hematological malignancies."
33019880,Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h,"methods: adult outpatients (aged 18-75 years), with an eastern cooperative oncology group (ecog) performance status of 0-2, bearing solid tumors and candidates for intravenous chemotherapy were eligible for the study."
33019880,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"exclusion criteria were active infections, coagulopathy (defined as platelet count <50,000/μl and/or prothrombin time more than 18 s), life expectancy <6 months, or inability to give written informed consent."
33019880,PICC infection,"exclusion criteria were active infections, coagulopathy (defined as platelet count <50,000/μl and/or prothrombin time more than 18 s), life expectancy <6 months, or inability to give written informed consent. there were n = 13 (2.7%) thromboses, n = 11 (2.3%) irreversible occlusions, n = 7 (1.5%) accidental removals, n = 5 (1.0%) infections [two catheter related blood stream infection (crbsi) and three exit site/local infection], n = 3 (0.6%) ruptures and n = 3 (0.6%) primary or secondary malpositions."
30348912,Gender,"the rate of blockage of piccs, proportion of male subjects, age of subjects, apache ii score and length of stay in hospital showed no significant differences between the two groups."
30348912,Age,"the rate of blockage of piccs, proportion of male subjects, age of subjects, apache ii score and length of stay in hospital showed no significant differences between the two groups."
30348912,PICC infection,we investigated whether a novel flushing method for piccs could decrease the risk of venous thromboembolism (vt) and catheter-associated bloodstream infections (cabsis) compared to the traditional flushing method.
33084898,PICC insertion procedure,"conclusions and relevance: this cohort study suggests that, when piccs were placed for intravenous antimicrobial therapy, infectious disease physician approval of picc insertion was associated with more appropriate device use and fewer complications."
33084898,PICC infection,"complications related to piccs included catheter occlusion, deep vein thrombosis, and central line-associated bloodstream infection."
28634973,Cancer,"piccs were restricted to cancer and infectious disease patients, and were followed up irrespective of the management setting (inpatient, outpatient or intermittently hospitalised after insertion)."
28634973,PICC infection,"during a total of 10 402 catheter-days (median dwell time 62 days), there were five central line-associated bloodstream infections, including one mucosal barrier injury laboratory-confirmed bloodstream infection and two exit-site infections, yielding incidence rates of 0.48 and 0.19 infections per 1000 catheter-days, respectively. infection prevention specialists should be actively involved during the introduction of new intravascular devices in order to provide quality indicators and assure patient safety."
28823518,Age,"forty-four patients were treated with rivaroxaban and 40 with initial lmw heparin and vitamin k antagonist with continuation of vitamin k antagonists alone once international normalized ratio was therapeutic findings: in the rivaroxaban group mean (sd) age was 51 (16) years and 57% were men, whereas in the other group respective values were 50 (16) years and 56%."
36676072,PICC infection,"however, it is well known that uvcs can lead to some serious complications, both mechanical and infective, including clabsi (central line-associated bloodstream infections). these guidelines also suggest as an infection prevention strategy to remove uvc after 4 days, followed by the insertion of a picc if a central line is still needed. in this study we reviewed a total of 177 articles, found by using the pubmed database with the following search strings: ""uvc and neonates"", ""(neonate* or newborn*) and (uvc or central catheter*) and (infection*)""."
27371372,PICC insertion procedure,"conclusions: our prospective study suggests that the rate of picc-related upper extremity venous thrombosis in oncology patients is high, and the occurrence of symptomatic thrombosis could be lowered with regular weekly doppler screening after picc insertions."
22948189,Surgery_type of surgery,"risk factors for crlvt including mannitol therapy during dwell time, previous history of venous thromboembolism, surgery longer than 1h during dwell time, and line placement in a paretic arm were also compared between groups."
22948189,PICC infection,"objective: to compare cumulative complication rates of peripherally (picc) and centrally (cicvc) inserted central venous catheters, including catheter-related large vein thrombosis (crlvt), central line-associated bloodstream infection (clabsi), and line insertion-related complications in neurological intensive care patients."
38157768,PICC infection,"complications analyzed included catheter related deep venous thrombosis (dvt), central line associated blood stream infection (clabsi), and catheter related central venous stenosis."
34177272,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"collected data points included patient demographics, comorbidities, central-line use, platelet count at time of scan, length of stay, and overall mortality. there were no significant differences in age, sex, race, or mean platelet levels between patients diagnosed with dvt and those without (p<0.05). conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt."
34177272,Hypertension,"after multinomial regression analysis, central venous catheter (cvc; 26.8% versus 78.5%, aor 1.770, 95% ci 1.150-2.725; p<0.002), peripherally inserted central catheter (picc) line (17.5% versus 82.5%, aor3.254, 95% ci 1.997-5.304; p<0.001), hypertension (67.8% versus 28.8%, aor 1.641, 95% ci 1.136-2.369; p<0.001), chronic kidney disease (ckd; 34.5% versus 65.5%, aor 1.743, 95% ci 1.201-2.531; p<0.001), and malignancy (27.1% versus 74.6%, aor 1.475, 95% ci 0.994-2.190; p<0.053) were found to be independent predictors of uedvt. conclusion: use of cvc or picc line, preexisting diagnosis of hypertension, malignancy, and ckd were independent risk factors of uedvt, while there was no significant correlation between increased platelet levels and uedvt."
28822403,ICU,"inpatient peripherally inserted central venous catheter complications: should peripherally inserted central catheter lines be placed in the intensive care unit setting? . peripherally inserted central venous catheters (piccs) are now commonly used for central access in the intensive care unit (icu) setting; however, there is a paucity of data evaluating the complication rates associated with these lines."
28822403,PICC infection,"the combined thrombotic and central line associated blood stream infection rate was 6.17 per cent in the non-icu group and 10.53 per cent in the icu group (p = 0.035). the thrombotic complication rate was 5.88 per cent in the non-icu group and 7.60 per cent in the icu group (p = 0.38), whereas the central line associated blood stream infection rate was 0.29 per cent in the non-icu group and 2.92 per cent in the icu group (p = 0.002)."
27957644,PICC insertion procedure,"tip malposition of peripherally inserted central catheters: a prospective randomized controlled trial to compare bedside insertion to fluoroscopically guided placement. the aim of our study was to compare the bst with the fluoroscopically guided technique (fgt), with specific regard to catheter tip position (ctp). depending on the international guidelines for optimal ctp, patients were classified in three types: optimal, suboptimal not needing repositioning, and nonoptimal requiring additional repositioning procedures. in the bst groups, 23.3% of placements were suboptimal and 30% nonoptimal, requiring repositioning. conclusion: tip malposition rates are high when using blind bst, exposing the patient to an increased risk of deep venous thrombosis and catheter malfunction. using the fgt or emerging technologies that could help tip positioning are recommended, especially for long-term indications. • catheter malposition is the major technical issue with the bedside technique. • catheter malposition occurred in 53% of patients with the bedside technique."
26369828,Cancer,"after systematic reviews of the literature, scenarios related to picc use, care, and maintenance were developed according to patient population (for example, general hospitalized, critically ill, cancer, kidney disease), indication for insertion (infusion of peripherally compatible infusates vs. in patients with cancer, piccs were rated as appropriate for irritant or vesicant infusion, regardless of duration."
26369828,PICC infection,"increasing use has led to the realization that piccs are associated with important complications, including thrombosis and infection."
23633980,Cancer,"upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factors. the purpose of this study was to ascertain risk factors associated with an increased risk of picc-associated uevt in patients with cancer. methods: retrospective analysis identified 237 patients with cancer who received piccs at the dallas veterans affairs medical center from 2006 to 2009. conclusion: specific factors significantly increase the risk of uevt in patients with cancer with piccs, whereas use of apas seems to have a protective effect against uevt."
23633980,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab."
23633980,PICC infection,"we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab."
23633980,Erythropoiesis-stimulating agents,"we analyzed many risk factors, including picc infection (pi), use of erythropoiesis-stimulating agents (esas), antiplatelet agents (apas), treatment dose anticoagulation (tda), and bevacizumab."
32043739,Cancer,"catheter-related thrombosis incidence and risk factors in adult cancer patients with central venous access devices. background: central venous access devices (cvad) are commonly employed in the management of cancer patients. aim: to review the incidence and risk factors for catheter-related thrombosis (crt) in cancer patients with a cvad. methods: we performed a prospective observational cohort study of adult patients with cancer requiring a cvad between 1 january 2004 and 29 june 2016. hodgkin lymphoma, germ cell and oesophagus cancers had the highest crt rates. cancer subtype and insertion side were not predictive of thrombosis."
32043739,Age,"older age groups developed crt at lower rates (hr 0.57; 95% ci 0.39-0.84 for age 50-61 years, and hr 0.63; 95% ci 0.45-0.89 for age >61 years) compared to age <50 years. conclusions: age <50 years, picc lines and prior crt were associated with highest crt rate."
23354238,ICU,"which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit. background: catheter-associated deep venous thromboses (cadvts) are a common occurrence in the surgical intensive care unit (sicu), necessitating central venous catheter (cvc) removal and replacement."
23354238,PICC indwelling time,"which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit. rates of cadvt were 9 per 1,000 catheter days for sc, 61 for ij (p < 0.01 vs."
30111976,Cancer,"perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey. background: the choice of vascular access for systemic therapy administration in breast cancer remains an area of clinical equipoise, and patient preference is not consistently acknowledged. using a patient survey, we evaluated the patient experience with vascular access during treatment for early-stage breast cancer and explored perceived risk factors for lymphedema. methods: patients who had received systemic therapy for early-stage breast cancer were surveyed at 2 canadian cancer centres."
24811603,PICC infection,one suspected catheter-associated bloodstream infection did occur in the picc group.
24811603,Blood vessel irritating drug_vancomycin_amphotericine,"safe administration of vancomycin through a novel midline catheter: a randomized, prospective clinical trial. background: according to the 2011 infusion nursing standards of practice, the low ph of intravenous vancomycin requires that it be administered through a central line. purpose: a prospective, controlled, randomized clinical trial was conducted to determine if intravenous vancomycin could be safely administered through a novel midline catheter (powerwand®, access scientific, san diego, ca). methods: patients scheduled to receive short-term (<6 days) intravenous vancomycin were randomly assigned to receive treatment through either a peripherally inserted central catheter (picc) or the midline study device. conclusions: short-term intravenous vancomycin can be safely and cost-efficiently administered in the deep vessels of the upper arm using the midline study device."
31387123,PICC infection,"outpatient parenteral antibiotic therapy (opat) with peripherally inserted central catheter in patients with periprosthetic joint infection. background: a key factor in the successful treatment of periprosthetic joint infection is the consistent antimicrobial therapy. methods: we prospectively evaluated the systematic use of picc in 11 patients with periprosthetic joint infection. the occurrence of a catheter-related bloodstream infection (crbsi) was not recorded. none of our patients had picc-associated infections, thrombophlebitis or thrombosis. at a mean follow-up of 29 months, successful infection eradication as measured by the delphi criteria was achieved in 100%. antimicrobial therapy for treatment of periprosthetic joint infection. the successful infection control in all cases despite proven difficult-to-treat infection is promising."
31565960,PICC infection,"the primary end point was the incidence of composite catheter-related adverse events that included local events, catheter dislodgment, infiltration, catheter occlusion, catheter-related venous thromboembolism, extravasation, and line-associated infection."
31464692,Chemotherapy,"background: peripherally inserted central catheters (piccs) and implantable port catheters (ipcs) are 2 most common central venous access for cancer patients receiving chemotherapy. objective: to compare the differences of complications and costs of picc and ipc in the treatment of cancer patients with chemotherapy and to provide a basis for better clinical decision making. conclusions: implantable port catheter has advantages over picc in reducing cancer patients' complications and less cost in terms of long-term cancer chemotherapy. implications for practice: in terms of safety, the results provide evidence for practitioners to choose which type of central venous catheters is better for cancer chemotherapy patients."
31464692,Cancer,"complications and costs of peripherally inserted central venous catheters compared with implantable port catheters for cancer patients: a meta-analysis. background: peripherally inserted central catheters (piccs) and implantable port catheters (ipcs) are 2 most common central venous access for cancer patients receiving chemotherapy. objective: to compare the differences of complications and costs of picc and ipc in the treatment of cancer patients with chemotherapy and to provide a basis for better clinical decision making. conclusions: implantable port catheter has advantages over picc in reducing cancer patients' complications and less cost in terms of long-term cancer chemotherapy. implications for practice: in terms of safety, the results provide evidence for practitioners to choose which type of central venous catheters is better for cancer chemotherapy patients."
31464692,PICC insertion procedure,"peripherally inserted central catheter use was associated with higher complication rates than ipc, including occlusion, infection, malposition, catheter-related thrombosis, extravasation, phlebitis, and accidental removal rate."
31464692,PICC infection,"peripherally inserted central catheter use was associated with higher complication rates than ipc, including occlusion, infection, malposition, catheter-related thrombosis, extravasation, phlebitis, and accidental removal rate."
23697825,Cancer,"in the non-comparison studies, the weighted frequency of picc-related deep vein thrombosis was highest in patients who were critically ill (13·91%, 95% ci 7·68-20·14) and those with cancer (6·67%, 4·69-8·64)."
36299679,Chemotherapy,"functions of heparin sodium injection in the prevention of peripherally inserted central catheter-related venous thrombosis in nsclc patients during postoperative chemotherapy. objective: this study intended to analyze hazardous factors of venous thrombosis by comparing the effect of different doses of heparin sodium injection on the incidence rate of peripherally inserted central catheter (picc)-related venous thrombosis in non-small cell lung carcinoma (nsclc) patients during postoperative chemotherapy. based on their different pathological types, patients were given two different chemotherapy regimens: pemetrexed+cisplatin or paclitaxel+cisplatin. conclusion: heparin sodium could significantly lower the incidence rate of picc-related venous thrombosis in nsclc patients during postoperative chemotherapy."
36299679,Cancer,"methods: 425 nsclc patients who received picc catheterization in cancer hospital chinese academy of medical sciences, shenzhen hospital from july 2019 to july 2021 were collected. objective: this study intended to analyze hazardous factors of venous thrombosis by comparing the effect of different doses of heparin sodium injection on the incidence rate of peripherally inserted central catheter (picc)-related venous thrombosis in non-small cell lung carcinoma (nsclc) patients during postoperative chemotherapy."
24436591,Gender,"patients were analyzed for age, gender, race, site of thrombosis, coagulation factors, lipid panel, type of antiretroviral treatment, past or present history of infections or malignancy, cd4 absolute and helper cell counts at the beginning of thrombosis, response to treatment and outcome. all were male patients with six patients having lower limb thrombosis, one patient with upper limb thrombosis related to peripheral inserted central catheter (picc), and one patient had pulmonary embolism with no deep vein thrombosis. conclusion thrombosis in hiv patients is seen more commonly in middle aged, community ambulant male patients."
24436591,PICC infection,"there are several intersecting mechanisms associated with hiv infection and antiviral therapy that are emerging, which may lead to vasculopathy and hypercoagulability in these patients. patients were analyzed for age, gender, race, site of thrombosis, coagulation factors, lipid panel, type of antiretroviral treatment, past or present history of infections or malignancy, cd4 absolute and helper cell counts at the beginning of thrombosis, response to treatment and outcome."
35815563,Anticoagulants therapy,"results: anticoagulants resulted a protective factor mostly for partial cvc occlusion (p = 0.0001), preventing cvc occlusions."
35701467,Diabete,"compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus."
35701467,BMI,"compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus. multivariable logistic regression analysis showed that bmi (p = 0.03) was a significant risk factor for crt."
35701467,Age,"compared to the crt-free group, the crt group was older and showed higher body mass index (bmi), leukocyte count level, and the prevalence of diabetes mellitus."
37349797,Age,"the cases highlight that clinicians should have a low threshold to utilise imaging modalities such as computerised tomography and transthoracic echocardiography when there is an untoward change in physiological parameters among patients with peripherally inserted central catheters, particularly those with risk factors for peripherally inserted central catheter associated venous thrombosis."
29148000,Cancer,"methods: from october 2010 to december 2014, 221 cancer patients with svcs in our center received real-time ultrasound-guidance of the superficial femoral vein inserted central catheters (ficcs) at the mid-thigh. picc insertion via upper extremity veins had also been investigated in 2604 cancer patients without svcs as control."
29148000,PICC insertion procedure,"the major complications included skin allergy to chlorhexidine gluconate (chg) dressings, exudation, catheter-related infection, catheter occlusions, unplanned catheter withdrawal, venous thrombosis, mechanical phlebitis, and catheter malposition. it is interesting that a higher rate of catheter malposition was observed in the upper extremity veins picc group than in the ficc group (2.15% vs. picc insertion via upper extremity veins had also been investigated in 2604 cancer patients without svcs as control."
29377971,Two or more lumens,"compared to piccs placed for >5 days, variables associated with short-term piccs included difficult venous access (odds ratio [or], 1.54; 95% confidence interval [ci], 1.40-1.69), multilumen devices (or, 1.53; 95% ci, 1.39-1.69), and teaching hospitals (or, 1.25; 95% ci, 1.04-1.52)."
29377971,PICC infection,"complications associated with short-term use, including major (eg, venous thromboembolism [vte] or central lineassociated bloodstream infection [clabsi]) or minor (eg, catheter occlusion, tip migration) events were assessed."
25120012,Chemotherapy,"purpose: few prospective follow-up studies evaluating the use of peripherally inserted central catheters (piccs) to deliver chemotherapy and/or home parenteral nutrition (hpn) have focused exclusively on oncology outpatients. all patients received hpn and 71 % received chemotherapy during the study period. the main findings of this study were that, if accurately managed, piccs can be safely used in cancer patients receiving chemotherapy and/or hpn, recording a low incidence of crbsi, thrombosis, and mechanical complications; a long catheter life span; and a low probability of catheter removal because of complications."
25120012,Cancer,"peripherally inserted central catheters in non-hospitalized cancer patients: 5-year results of a prospective study. the aim of this prospective study was to assess the reliability and the safety of piccs over a 5-year use in non-hospitalized cancer patients requiring long-term intravenous therapies. the main findings of this study were that, if accurately managed, piccs can be safely used in cancer patients receiving chemotherapy and/or hpn, recording a low incidence of crbsi, thrombosis, and mechanical complications; a long catheter life span; and a low probability of catheter removal because of complications. conclusions: our study suggests that piccs can be successfully utilized as safe and long-lasting venous access devices in non-hospitalized cancer patients."
25120012,PICC indwelling time,"results: two hundred sixty-nine piccs in 250 patients (98 % with solid malignancies) were studied, for a total of 55,293 catheter days (median dwell time 184 days, range 15-1,384). the incidence of catheter-related bloodstream infections (crbsis) was low (0.05 per 1,000 catheter days), picc-related symptomatic thrombosis was rare (1.1 %; 0.05 per 1,000 catheter days), and mechanical complications were uncommon (13.1 %; 0.63 per 1,000 catheter days). the overall complication rate was 17.5 % (0.85 per 1,000 catheter days) and piccs were removed because of complications only in 7 % of cases."
25120012,Total parenteral nutrition,purpose: few prospective follow-up studies evaluating the use of peripherally inserted central catheters (piccs) to deliver chemotherapy and/or home parenteral nutrition (hpn) have focused exclusively on oncology outpatients.
25120012,PICC infection,"the incidence of catheter-related bloodstream infections (crbsis) was low (0.05 per 1,000 catheter days), picc-related symptomatic thrombosis was rare (1.1 %; 0.05 per 1,000 catheter days), and mechanical complications were uncommon (13.1 %; 0.63 per 1,000 catheter days)."
34842905,Two or more lumens,"after adjusting for patient characteristics, comorbidities, catheter lumens, and dwell time in logit models, patients who received piccs had a greater risk of developing a major complication compared with those who received midlines (odds ratio, 1.99; 95% ci, 1.61-2.47)."
34842905,Number of comorbidities/HTA/Hyperglycemia,"after adjusting for patient characteristics, comorbidities, catheter lumens, and dwell time in logit models, patients who received piccs had a greater risk of developing a major complication compared with those who received midlines (odds ratio, 1.99; 95% ci, 1.61-2.47)."
34842905,PICC infection,"main outcomes and measures: major complications, including a composite of symptomatic catheter-associated deep vein thrombosis (dvt), catheter-related bloodstream infection, and catheter occlusion. reduction in complications stemmed from lower rates of occlusion (2.1% vs 7.0%; p < .001) and bloodstream infection (0.4% vs 1.6%; p < .001) in midlines vs piccs; no significant difference in the risk of dvt between piccs and midlines was observed. in time-to-event models, similar outcomes for bloodstream infection and catheter occlusion were noted; however, the risk of dvt events was lower in patients who received piccs vs midlines (hazard ratio, 0.53; 95% ci, 0.38-0.74). conclusions and relevance: in this cohort study among patients with placement of midline catheters vs piccs for short-term indications, midlines were associated with a lower risk of bloodstream infection and occlusion compared with piccs."
26339941,Gender,"patient factors-including greater age, height, and weight, as well as male gender-were associated with increased vein diameter."
33173567,Surgery_type of surgery,"this complication is more serious among patients with single ventricle physiology, as it might preclude them from undergoing further life-sustaining palliative surgery."
37254629,Cancer,"complication rates of peripherally inserted central catheters vs implanted ports in patients receiving systemic anticancer therapy: a retrospective cohort study. while implanted port catheters (""ports"") have historically been the standard device for intravenous systemic anticancer therapy, the use of peripherally inserted central catheters (piccs) has increased continuously and reliable catheter selection guidelines are lacking. we compare complication rates of ports and piccs in cancer treatment in a retrospective study of 3365 patients with both solid organ (n = 2612) and hematologic (n = 753) malignancies, between 2001 and 2021."
37254629,PICC infection,"among major complications, infections and mechanical complications were more common in piccs than in ports (11.9% vs 6.4%, p = .001, 7.3% vs 4.2%, p = .002), whereas the rate of thrombosis was similar (3.4% vs 3.0%, p = .9)."
32943968,Cancer,"central venous catheter thrombosis in cancer: a multi-centre retrospective study investigating risk factors and contemporary trends in management. objectives: central venous access is needed to facilitate chemotherapy for many cancer patients. we sought to explore the rate of cvct in a general cancer population in australia and to identify factors associated with increased risk of thrombosis. setting and participants: we analysed key patient, treatment, and cancer-related factors for 317 patients with cancer and central venous catheters inserted for systemic therapy. conclusions: this work explored rates of cvct in a general cancer population, observing increased rates in those with piccs or increased body mass index."
32943968,BMI,"having a peripherally inserted central catheter (picc; hr = 3.78, 95% ci = 1.28-11.19, p = .02) compared with an implantable port and a body mass index of ⩾25.0 kg/m(2) (hr = 3.60, 95% ci = 1.31-9.85, p = .01) were independently associated with increased risk of thrombosis. conclusions: this work explored rates of cvct in a general cancer population, observing increased rates in those with piccs or increased body mass index."
37166852,Gender,"age (median [interquartile range]: 68.7 [58.6-75.7], 66.6 [57.1-75.0], and 67.6 [58.7-75.8] yr) and gender (percentage female: 50.5%, 47.3%, and 43.8%) were similar in all groups."
25374804,ICU,"some limits previously ascribed to piccs (i.e., low flow rates, difficult central venous pressure monitoring, lack of safety for radio-diagnostic procedures, single-lumen) have delayed their start up in the intensive care units as common practice."
25374804,PICC insertion procedure,"using the ultrasound-guidance for the picc insertion, the risk of hemothorax and pneumothorax can be avoided, as well as the possibility of primary malposition is very low."
25374804,Performans score_performance status_karnofsky_ECOG_Less activity_bedridden > 72h,"second, an inappropriate cvad choice and, particularly, an inadequate insertion technique are relevant-and often not recognized-potential risk factors for complications in critically ill patients."
26623068,PICC infection,"thrombosis is a frequent complication that should be ruled out, as it is associated with potentially severe infection and hemodynamic consequences."
33388763,Age,"mean age [standard error of the mean] was 38.74 [0.06] years (range, 18-74 years), and 54% were female. from multivariate regression analysis, previous vte (odds ratio [or], 52.8; 95% confidence interval [ci], 35.2-78.6; p < 0.0001), peripherally inserted central catheter (picc)/central line placement (or, 19.6; 95% ci, 9.8-153; p < 0.05), rib graft (or, 4.6; 95% ci, 2.3-8.5; p < 0.0001), age 41 to 60 years (or, 2.65; 95% ci, 1.7-4.3; p < 0.01), inflammatory bowel disease (ibd) (or, 2.6; 95% ci, 1.0-5.5; p < 0.05), and age 61 to 74 years (or, 2.4; 95% ci, 1.2-4.8; p < 0.05) were associated with an increased risk of vte."
33388763,"Others (COPD, IBD)","from multivariate regression analysis, previous vte (odds ratio [or], 52.8; 95% confidence interval [ci], 35.2-78.6; p < 0.0001), peripherally inserted central catheter (picc)/central line placement (or, 19.6; 95% ci, 9.8-153; p < 0.05), rib graft (or, 4.6; 95% ci, 2.3-8.5; p < 0.0001), age 41 to 60 years (or, 2.65; 95% ci, 1.7-4.3; p < 0.01), inflammatory bowel disease (ibd) (or, 2.6; 95% ci, 1.0-5.5; p < 0.05), and age 61 to 74 years (or, 2.4; 95% ci, 1.2-4.8; p < 0.05) were associated with an increased risk of vte. previous vte, picc/central line, advancing age, ibd, and intraoperative rib graft harvest were most strongly associated with vte in this population cohort."
29659465,Diabete,"pruevt cases were more likely to be diabetic, but this did not reach statistical significance. the time that a picc was in place before pruevt was diagnosed was longer for diabetic patients, but the authors believe this result must be viewed with caution."
29659465,Number of comorbidities/HTA/Hyperglycemia,does hyperglycemia affect risk of peripherally inserted central catheter-related upper extremity venous thrombosis? .
30795912,PICC indwelling time,"complications/1000 catheter days were extracted, and a poisson model was used to compare complications between piccs and broviacs®. results: thirty-seven patients with if were included, accounting for 19,452 catheter days. incidences of central line associated blood stream infection and venous thrombosis were 3.95 and 0.55 per 1000 catheter days, respectively. there were no significant differences in complication rates per line per catheter day between piccs and broviacs® on multivariate analysis."
30795912,PICC infection,"incidences of central line associated blood stream infection and venous thrombosis were 3.95 and 0.55 per 1000 catheter days, respectively."
36113076,PICC indwelling time,"median dwelling time of cvads was 172 days, for a total number of 39,044 catheter days. a very low incidence of both symptomatic catheter-related thrombosis (0.9%) and catheter-related blood stream infection (0.56 episodes per 1000 catheter days) was found."
36113076,PICC infection,a very low incidence of both symptomatic catheter-related thrombosis (0.9%) and catheter-related blood stream infection (0.56 episodes per 1000 catheter days) was found.
29293304,PICC infection,"while generally safe, cvads can be associated with complications such as catheter occlusion or rupture, venous thrombosis, and bloodstream infection. a number of strategies have been used to minimize the occurrence of cvad- and picc-associated complications such as antimicrobial-impregnated lines for prevention of infection, or addition of a valve (valved catheters) to prevent occlusion by preventing reflux of blood into the catheter."
35285085,PICC infection,"we compared the safety of the two types of devices in a homogeneous and monocentric population of diffuse large b-cell lymphoma (dlbcl) patients who were treated with first-line immunochemotherapy by evaluating the numbers of catheter-related venous thromboses (vts) and infections that occurred in the six months after implantation according to the type of device. methods: using a propensity score, the adjusted relative risk (arr) between the type of catheter and the occurrence of catheter-related complications (infection and/or vt) of interest was retrospectively determined. results: 479 patients were enrolled (266 ports/213 piccs), and 26 vts (5.4%) and 30 infections (6.3%) were identified in the period following picc/port implantation. the adjusted relative risk (arr) of catheter-related complications (infection and/or vt) according to the type of device was 2.6 (95% ci =1.3-5.9, p = .0075). this risk increase associated with the picc device was significant for both infections (arr = 3.2; 95% ci = 1.3-10.9) and thrombosis (arr = 4; 95% ci = 1.5-11.6)."
34148390,PICC infection,"in patients with cta-tunneled external catheters, there were two dislodgments, four episodes of central line associated blood stream infections, and one local infection."
32205131,Chemotherapy,"patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy. objective: peripherally inserted central venous catheter (picc)-related thrombosis (prt) is a serious complication that can lead to interruptions in chemotherapy and other supportive care, as well as increased hospital stay and costs. we conducted a retrospective study to evaluate the patterns of symptomatic prt in patients with cancer undergoing chemotherapy and their risk factors. predictors associated with increased risk of prt were age >60 years (odds ratio [or], 2.142; 95% confidence interval [ci], 1.118-4.103) and a chemotherapy regimen containing fluorouracil (or, 2.429; 95% ci, 1.013-5.825). conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy."
32205131,Cancer,"we conducted a retrospective study to evaluate the patterns of symptomatic prt in patients with cancer undergoing chemotherapy and their risk factors. the symptomatic svt occurred in 42 of 938 patients with cancer (4.5%), which accounted for 68.9% of all uevt events. conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy. piccs-related svt was a frequent type of prt, which might need a better understanding and anticoagulant therapy in patients with cancer with piccs."
32205131,Age,"predictors associated with increased risk of prt were age >60 years (odds ratio [or], 2.142; 95% confidence interval [ci], 1.118-4.103) and a chemotherapy regimen containing fluorouracil (or, 2.429; 95% ci, 1.013-5.825). conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy."
32205131,Hypertension,"hypertension with medication was a protective factor for prt (or, 0.306; 95% ci, 0.113-0.828). conclusions: age >60 years and chemotherapy regimens containing fluorouracil were independent risk factors for prt and hypertension with medication was associated with a lower risk of prt in patients with cancer with piccs receiving chemotherapy."
27792437,PICC indwelling time,"following the change in needle-free connector, 180 piccs were inserted by the vascular access team on one of the organisation's sites over a 12-month period, with a total dwell time of 9702 catheter days (mean: 53.9 days, median: 35 days), a pwo rate of 1/1000 catheter days and total occlusion rate of 0.4/1000 catheter days."
25191821,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"not being on any form of anticoagulant or antiplatelet agent was associated with a modestly increased risk of pruevt (odds ratio 1.93, p = .036, 95% confidence interval, 1.025-3.602)."
25191821,Anticoagulants therapy,"not being on any form of anticoagulant or antiplatelet agent was associated with a modestly increased risk of pruevt (odds ratio 1.93, p = .036, 95% confidence interval, 1.025-3.602)."
30513003,PICC insertion procedure,"introduction: thrombotic complications associated with peripherally inserted central catheters (piccs) are common, as most synthetic materials when placed in the presence of serum often result in platelet activation, fibrin deposition, thrombotic occlusion, and potentially embolization."
30513003,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"introduction: thrombotic complications associated with peripherally inserted central catheters (piccs) are common, as most synthetic materials when placed in the presence of serum often result in platelet activation, fibrin deposition, thrombotic occlusion, and potentially embolization."
24090605,Chemotherapy,"introduction: central venous catheters (cvc) related thrombosis (crt) represents a well known complication in patients with acute myeloid leukemia (aml) receiving intensive chemotherapy but the efficacy of antithrombotic prophylaxis still remains controversial. patients and methods: we analyzed 71 consecutive aml patients whose cvc was inserted before each chemotherapy cycle for an overall number of 106 cvc placements. conclusion: our retrospective study, although based on a small sample size, suggests that the occurrence of cvc-exit site infections and neutropenic sepsis following chemotherapy significantly increases the risk of crt in aml, independently from the use of lmwh prophylaxis."
24090605,Cancer,infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia. introduction: central venous catheters (cvc) related thrombosis (crt) represents a well known complication in patients with acute myeloid leukemia (aml) receiving intensive chemotherapy but the efficacy of antithrombotic prophylaxis still remains controversial.
24090605,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),lmwh was delivered regardless of the platelet (plt) count once provided that it should have been maintained above 20 x 10(9)/l by transfusions.
24090605,PICC infection,"infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia. results: of 106 insertions, we observed 19 (18%) episodes of crt, 58 (54%) of sepsis and 50 (47%) infections of cvc-exit site with no difference between lmwh and no-lmwh group. occurrence of crt was significantly associated with cvc-exit site infections (14/19, p=0.01) and sepsis (16/19, p=0.005) with no difference between lmwh and no-lmwh group. in multivariate analysis, both cvc-exit site infections and sepsis were confirmed to be independent risk factors for crt development. conclusion: our retrospective study, although based on a small sample size, suggests that the occurrence of cvc-exit site infections and neutropenic sepsis following chemotherapy significantly increases the risk of crt in aml, independently from the use of lmwh prophylaxis."
32375605,PICC insertion procedure,"randomized multicenter study on long-term complications of peripherally inserted central catheters positioned by electrocardiographic technique. this randomized clinical trial aimed to evaluate the long-term complications of peripherally inserted central catheters (piccs) positioned by the ic-ecg method. methods: we randomized 2250 patients who needed picc placement to either a landmark length estimation supplemented by ic-ecg positioned group (ecg group) or the traditional landmark length estimation alone group (control group) in a 2:1 allocation. post-procedural chest x-rays were applied to confirm tip position. results: as evaluated by post-procedural chest x-ray, tip location in the ecg group had a first-attempt success (catheter tip located at optimal position) of 91.7% (95% confidence interval (ci): 90.3%-93.1%), significantly higher than 78.9% (95% ci: 76.0%-81.9%) observed in the control group (p < 0.001)."
32375605,PICC infection,"at six-month follow-up, in the control group, frequency of total complications was 9.5%, including the exit site infection (4.0%), phlebitis (1.3%), deep venous thrombosis (1.5%), liquid extravasation (2.9%) and mechanical failure (1.9%). the ic-ecg group had significantly lower rates of complications (6.4%, p < 0.001), including the exit site infection (2.7%, p > 0.05), phlebitis (1.1%, p > 0.05), deep venous thrombosis (1.2%, p > 0.05), liquid extravasation (2.4%, p > 0.05) and mechanical failure (1.2%, p > 0.05)."
37205327,Cancer,"other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use."
37205327,Gender,"other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use."
37205327,Biology ( blood platelet level_white blood cell level_triglycerides_fibrinogen),"other risk factors included age, male sex, decreased platelet count, increased inr, increased ptt, decreased gfr, icu admission, cvc or picc placement, active cancer, coagulopathy, and in-hospital antiplatelet drug, steroid, or ssri use."
30909723,Two or more lumens,to compare incidence of cr thrombosis between mcs and piccs and to evaluate the impact of quantity of lumens and catheter diameter on cr thrombosis.
30589718,PICC insertion procedure,"however, central vascular access devices are associated with a risk of complications, which may include infection, thrombosis, occlusion, or malposition."
30589718,PICC infection,"however, central vascular access devices are associated with a risk of complications, which may include infection, thrombosis, occlusion, or malposition. no infections occurred during this study."
23002096,Cancer,"catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days. background: although home parenteral nutrition (hpn) is often indicated in cancer patients, many physicians are concerned about the risks potentially associated with the use of central venous access devices (vads) in these patients. the aim of this prospective study was to investigate the actual incidence of vad-related complications in cancer patients on hpn. methods: all adult cancer patient candidates for vad insertion and hpn were enrolled. conclusions: in cancer patients, hpn can be safely carried out with a low incidence of complications."
23002096,Total parenteral nutrition,"catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days. background: although home parenteral nutrition (hpn) is often indicated in cancer patients, many physicians are concerned about the risks potentially associated with the use of central venous access devices (vads) in these patients."
23002096,PICC infection,"the incidence of catheter-related bloodstream infections (crbsis) was low (0.35/1000 catheter-days), particularly for piccs (0/1000; p < .01 vs hohn and tunneled catheters) and for ports (0.19/1000; p < .01 vs hohn and p < .05 vs tunneled catheters)."
25656251,PICC infection,"no catheter-associated bloodstream infection occurred; main complications were symptomatic upper limb deep vein thrombosis (2%), catheter obstruction (18%) and persistent pain after catheter insertion (18%)."
25198813,Power injectable PICC,"purpose: few randomized studies have investigated the impact of valved and non-valved power-injectable peripherally inserted central catheters (piccs) in terms of incidence of occlusion, infection, malfunction and venous thrombosis. one hundred and eighty adult patients candidate to chemotherapy were randomized into three groups: power-injectable piccs with solo-2 proximal valve (bard); power-injectable piccs with pasv (pressure activated safety valve) proximal valve (navilyst); and non-valved power-injectable piccs (medcomp)."
25198813,Chemotherapy,one hundred and eighty adult patients candidate to chemotherapy were randomized into three groups: power-injectable piccs with solo-2 proximal valve (bard); power-injectable piccs with pasv (pressure activated safety valve) proximal valve (navilyst); and non-valved power-injectable piccs (medcomp).
25198813,PICC infection,"purpose: few randomized studies have investigated the impact of valved and non-valved power-injectable peripherally inserted central catheters (piccs) in terms of incidence of occlusion, infection, malfunction and venous thrombosis. results: we detected no complications at insertion; no picc-related bloodstream infections; no dislocations; five cases of transient occlusion and two cases of persistent withdrawal occlusion, evenly distributed among the groups; one episode of complete irreversible obstruction (group a); four episodes of asymptomatic peripheral venous thrombosis; one episode of symptomatic, severe central vein thrombosis (group b)."
34980518,PICC infection,"thrombosis and infections of peripherally inserted central catheters in burn patients: a 3-year retrospective study and a systematic review. burn patients need special considerations because of restricted insertion sites, burn wounds, hyper coagulation, high infection rates and others. this study aims to investigate the thrombosis and infections of piccs in burn patients. upper extremity vein thrombosis (uevt) and central line-associated bloodstream infection (clabsi) were the main outcome."
33298237,PICC indwelling time,"results: in total, 1,142 piccs were inserted, with 153,191 catheter days (median, 79). complications included 66 cases of cabsi (5.78%; 0.43‰ catheter days), 38 cases of crbsi (3.33%; 0.25‰ catheter days), 28 cases of pb (2.45%; 0.18‰ catheter days), and 23 cases of uedvt (2.01%; 0.15‰ catheter days). compared to pb, crbsi showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection."
33298237,Total parenteral nutrition,"parenteral nutrition (odds ratio [or], 3.40; 95% confidence interval [ci], 1.77-6.52) and admission to the hematology ward (or, 4.90; 95% ci, 2.25-10.71) were independently associated with crbsi and pb, respectively."
33298237,PICC infection,"methods: catheter-associated bloodstream infection (cabsi) including catheter-related bloodstream infection (crbsi), primary bacteremia (pb), and upper extremity deep vein thrombosis (uedvt) were recorded. the median times to infection were 24, 41, and 60 days for crbsi, pb, and uedvt, respectively. compared to pb, crbsi showed significantly different risk factors, a higher incidence density per catheter days, and a shorter median time to infection."
33298237,Hospitalisation/ Medical department admission/ discharged to a skilled-nursing facility,"parenteral nutrition (odds ratio [or], 3.40; 95% confidence interval [ci], 1.77-6.52) and admission to the hematology ward (or, 4.90; 95% ci, 2.25-10.71) were independently associated with crbsi and pb, respectively. admission to the hematology ward (or, 12.46; 95% ci, 2.49-62.50) or to the oncology ward (or, 7.89; 95% ci, 1.77-35.16) was independently associated with uedvt."
23710585,Chemotherapy,"the multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis. the history of chemotherapy, less activities and diabetes were found to be the key risk factors."
23710585,Diabete,"the multivariable analyses showed that chemotherapy history, less activities and diabetes were the key risk factors for thrombosis. the history of chemotherapy, less activities and diabetes were found to be the key risk factors."
23710585,Cancer,"risk factors associated with picc-related upper extremity venous thrombosis in cancer patients. aims and objectives: to investigate the incidence and risk factors for peripherally inserted central venous catheters-related upper extremity venous thrombosis in patients with cancer. background: with the widespread use of peripherally inserted central venous catheters, peripherally inserted central venous catheters-related upper extremity venous thrombosis in patients with cancer leads to increasing morbidity and mortality. design and methods: consecutive patients with cancer who were scheduled to receive peripherally inserted central venous catheters, between september 2009 and may 2012, were prospectively studied in our centre. results: a total of 89 patients with cancer were studied in our research."
31674857,Chemotherapy,"picc-port totally implantable vascular access device in breast cancer patients undergoing chemotherapy. background and objectives: the increasing use of arm totally implantable vascular access devices for breast cancer patients who require chemotherapy has led to a greater risk of complications and failures and, in particular, to upper extremity deep vein thrombosis. a prospective study was conducted on 418 adult female breast cancer patients undergoing chemotherapy. conclusion: the peripherally inserted central catheter-port is a safe vascular device for chemotherapy delivery that achieves similar clinical results as traditional long-term vascular access devices (peripherally inserted central catheter and arm totally implantable vascular access device, in particular) in breast cancer patients."
31674857,Cancer,"picc-port totally implantable vascular access device in breast cancer patients undergoing chemotherapy. background and objectives: the increasing use of arm totally implantable vascular access devices for breast cancer patients who require chemotherapy has led to a greater risk of complications and failures and, in particular, to upper extremity deep vein thrombosis. this study aims to investigate the outcomes of the arm peripherally inserted central catheter-port technique in breast cancer patients. a prospective study was conducted on 418 adult female breast cancer patients undergoing chemotherapy. conclusion: the peripherally inserted central catheter-port is a safe vascular device for chemotherapy delivery that achieves similar clinical results as traditional long-term vascular access devices (peripherally inserted central catheter and arm totally implantable vascular access device, in particular) in breast cancer patients."
31674857,BMI,"with regard to the patients' characteristics, body mass index <22.5 was the only significant risk for failure (p = 0.027)."
34399039,Cancer,"the negative predictive value of peripherally inserted central catheter-associated vein thrombosis in the cancer group (80.0%, 95% ci: 73.2%-85.4%) was higher than that of the non-cancer group (60.0%, 95% ci: 35.7%-80.2%)."
25940453,Number of comorbidities/HTA/Hyperglycemia,"peripherally inserted central catheter presence, comorbidities, venous thrombosis risk factors, and thrombotic events within 90 days from hospital admission were ascertained by phone and record review."
25940453,Hospitalisation/ Medical department admission/ discharged to a skilled-nursing facility,"from hospital admission to 90 days, 876 thromboembolic events (208 upper-extremity deep vein thromboses, 372 lower-extremity deep vein thromboses, and 296 pulmonary emboli) were identified."
27126759,Diabete,"for patients with difficult intravenous access, those requiring multiple attempts, those who are obese, or have diabetes or other chronic conditions, determining the vascular access device (vad) with the lowest risk that best meets the needs of the treatment plan can be confusing."
32205954,ICU,abbreviations list: abhr: alcohol-based hand rub; aicd: automated implantable cardioverter defibrillator; bsi: blood stream infection; c/ss: chg/silver sulfadiazine; cath lab: catheterization laboratory (cardiac cath lab); cdc: centers for disease control and prevention; cfu: colony forming unit; chg: chlorhexidine gluconate; cl: central line; combux: comparison of bedside ultrasound with chest x-ray (combux study); cqi: continuous quality improvement; crbsi: catheter-related blood stream infection; cus: chest ultrasonography; cvc: central venous catheter; cxr: chest x-ray; dttp: differential time to positivity; dvt: deep venous thrombosis; ecg: electrocardiography; elvis: ethanol lock and risk of hemodialysis catheter infection in critically ill patients; er: emergency room; fda: food and drug administration; fv: femoral vein; gwe: guidewire exchange; hd catheter: hemodialysis catheter; hts: hypertonic saline; icp: intracranial pressure; icu: intensive care unit; idsa: infectious disease society of america; ijv: internal jugular vein; ipc: indian penal code; irr: incidence rate ratio; isccm: indian society of critical care medicine; iv: intravenous; lcbi: laboratory confirmed blood stream infection; m/r: minocycline/rifampicin; mbi-lcbi: mucosal barrier injury laboratory-confirmed bloodstream infection; mrsa: methicillin-resistant staphylococcus aureus; nhs: national health service (uk); nhsn: national healthcare safety network (usa); ot: operation theater; picc: peripherally-inserted central catheter; piv: peripheral intravenous line; pl: peripheral line; pvi: povidone-iodine; ra: right atrium; rct: randomized controlled trial; rr: relative risk; scv/sv: subclavian vein; scvo(2): central venous oxygen saturation; sn: sensitivity; sop: standard operating procedure; svc: superior vena cava; tee: transesophageal echocardiography; upp: useful practice points; usg: ultrasonography; who: world health organization.
32205954,PICC infection,"results: this document makes recommendations about various aspects of resource preparation, infection control, prevention of mechanical complication and surveillance related to short-term central venous catheterization. abbreviations list: abhr: alcohol-based hand rub; aicd: automated implantable cardioverter defibrillator; bsi: blood stream infection; c/ss: chg/silver sulfadiazine; cath lab: catheterization laboratory (cardiac cath lab); cdc: centers for disease control and prevention; cfu: colony forming unit; chg: chlorhexidine gluconate; cl: central line; combux: comparison of bedside ultrasound with chest x-ray (combux study); cqi: continuous quality improvement; crbsi: catheter-related blood stream infection; cus: chest ultrasonography; cvc: central venous catheter; cxr: chest x-ray; dttp: differential time to positivity; dvt: deep venous thrombosis; ecg: electrocardiography; elvis: ethanol lock and risk of hemodialysis catheter infection in critically ill patients; er: emergency room; fda: food and drug administration; fv: femoral vein; gwe: guidewire exchange; hd catheter: hemodialysis catheter; hts: hypertonic saline; icp: intracranial pressure; icu: intensive care unit; idsa: infectious disease society of america; ijv: internal jugular vein; ipc: indian penal code; irr: incidence rate ratio; isccm: indian society of critical care medicine; iv: intravenous; lcbi: laboratory confirmed blood stream infection; m/r: minocycline/rifampicin; mbi-lcbi: mucosal barrier injury laboratory-confirmed bloodstream infection; mrsa: methicillin-resistant staphylococcus aureus; nhs: national health service (uk); nhsn: national healthcare safety network (usa); ot: operation theater; picc: peripherally-inserted central catheter; piv: peripheral intravenous line; pl: peripheral line; pvi: povidone-iodine; ra: right atrium; rct: randomized controlled trial; rr: relative risk; scv/sv: subclavian vein; scvo(2): central venous oxygen saturation; sn: sensitivity; sop: standard operating procedure; svc: superior vena cava; tee: transesophageal echocardiography; upp: useful practice points; usg: ultrasonography; who: world health organization."
32551112,Two or more lumens,"results: of the factors evaluated, female gender, the use of triple lumen peripherally inserted central catheters, larger outer diameter, and open (vs valve) peripherally inserted central catheters were associated with venous thrombosis."
32551112,ICU,risk factors for peripherally inserted central catheter line-related deep venous thrombosis in critically ill intensive care unit patients. the objective of this case-control study was to identify the risk factors associated with peripherally inserted central catheter line-related deep venous thrombosis in critically ill medical-surgical intensive care unit patients in a community hospital.
32551112,Gender,"results: of the factors evaluated, female gender, the use of triple lumen peripherally inserted central catheters, larger outer diameter, and open (vs valve) peripherally inserted central catheters were associated with venous thrombosis."
